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ABSTRACT 
 
Pavak Kirit Shah: Micropallet Arrays as an Integrated Platform for the Characterization and 
Manipulation of Single Cells 
(Under the direction of Nancy L. Allbritton) 
 
 
 Cell isolations remain a critical bottleneck in cell biology. Fluorescence activated cell 
sorting (FACS) revolutionized the field by enabling rapid sorting of samples based on cell 
surface markers and bulk optical properties. Despite these advances, it remains impossible or 
prohibitively difficult to sort cells based on dynamic and morphological characteristics or to sort 
cells from extremely small samples such as are typically acquired from patient biopsies and 
small animal models. The work described in this dissertation is focused on the development of an 
integrated platform that can surmount the limitations of existing sorting technologies through the 
integration of a microfabricated platform and image cytometry. 
 The integration of simple microdevices such as microwell arrays with image-based 
cytometry has enabled temporally and spatially resolved single-cell measurements to be 
performed with high-throughput yet such instruments remain incapable of sorting cells based on 
this expanded feature-space. Micropallet arrays are a simple, scalable platform for performing 
high-throughput single-cell assays with spatial and temporal resolution. Individual elements from 
the array can also be released using low-energy laser pulses, enabling single-cell isolations to be 
performed with high purity and yield from extremely small samples.  
 A transparent, biocompatible and superparamagnetic composite photoresist was 
developed to enable the fabrication of micropallet arrays which could be manipulated by external 
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magnetic fields after release. This enabled the collection of released micropallets against gravity 
to improve the purity of sorts. An imaging cytometer was developed which combined high-
throughput automated image acquisition and analysis of micropallet arrays with automated laser-
based miropallet release for single-cell isolation. As a demonstration of the capability of 
micropallet arrays to sort exceedingly small and diverse samples as well as to characterize the 
performance of the automated platform, patient-derived xenograft tumor samples were sorted to 
yield pure populations of tumor cells from a mixture of tumor and host stromal tissue. This 
platform was subsequently applied to the study of the heterogeneity exhibited by monoclonal 
melanoma cell populations in their dynamic response to stimulation by Wnt-3a.  
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Chapter 1: Introduction 
1.1 The heterogeneity of biological systems 
1.1.1 Tumor diversity and evolution 
 Cancer remains the most commonly studied family of diseases and while advances in 
its detection and treatment have been made, significant gaps in the understanding of its 
emergence, evolution and metastasis remain. These advances have principally been driven by 
concurrent developments in genetic and molecular characterization techniques that have 
shaped and continue to shape our understanding of the disease. Perhaps the most critical recent 
advance in the development of anti-cancer therapeutics was the discovery of abnormalities of 
signaling pathways in cancer cells and their association, through genetic and molecular 
investigations, to specific enzymes. The identification of breast cancer bearing increased 
expression levels of ERBB2 and the production of the Bcr-Abl fusion kinase as a result of 
chromosomal translocation in three forms of leukemia (chronic myelogenous, acute 
lymphoblastic and acute myelogenous) led to the development of two of the most successful 
targeted cancer therapies (respectively, trastuzumab1 and imatinib2). 
 The success of these therapeutics has resulted in an explosion of novel targeted 
therapies, yet our understanding of cancer continues to evolve. Increasing instances of 
resistance to targeted inhibitor therapy3–6 called into question the simplified view of cancer as 
a monolithic disease and on-going work continues to build on the genetic and molecular 
understanding of cancer as a diverse, heterogeneous disease7,8. 
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 Advances in single-cell assays have greatly expanded an understanding of the diversity 
and heterogeneity present in seemingly simple biological systems. Advances in analytical tools 
for biochemical assays have significantly accelerated understanding the genomic8,9, 
transcriptional10–12 and proteomic13–15 heterogeneity present in biology and their role in 
governing normal and pathological function. A significant amount of focus has been given to 
cancer for characterization at the single-cell level and single-cell technologies continue to 
unravel the mechanisms by which cancers emerge16–18, evolve8,19,20 and metastasize18,21–23. 
While much of the integrative perspective on heterogeneity has been driven by so-called ‘-
omics’ approaches to analysis, more targeted investigations employing cytometric approaches 
have also made discoveries possible and are critical tools in the pipeline from basic discovery 
to the development of new diagnostics and therapeutics.24–30 
 Central to this understanding of cancer as a heterogeneous disease is the fundamental 
genetic instability of most cancers8. Intense growth pressure within tumors coupled with 
competition for nutrients and oxygen creates an environment well-suited to the selection of 
aggressive and robust mutants31. Single-cell sequencing investigations have shown that tumors 
typically evolve to consist of a small number of successful sub-clones as well as a large 
reservoir of cells which are rapidly mutating and genetically diverse8. This observation leads 
easily toward a model of cancer as an evolving population while also providing a potential 
explanation for the emergence of resistance to targeted therapy.  
1.1.2 Emerging perspectives on clonal heterogeneity 
 The observation of genetic8,9,19,20 and phenotypic10,21,23,32 diversity within tumors has 
led to significant interest in fundamental investigations of biological heterogeneity. A 
distinction must be made between the concepts of heterogeneity and biological noise. All 
20 
 
biological systems are subject to some degree of stochastic fluctuation13 although the majority 
of biological systems are sufficiently well regulated to prevent these fluctuations from 
significantly affecting cellular phenotype33. Phenotypic heterogeneity, however, can originate 
from a variety of different sources. Studying monoclonal populations in which genetic 
heterogeneity has been eliminated as a contributing factor has revealed a broad diversity in 
phenotypes present in seemingly homogeneous populations34–38. While the origin of this 
heterogeneity is poorly understood, it is widely believed to play a role in increasing the 
resistance of cancers to targeted inhibitor therapy3–8. 
1.1.3 Divide and Conquer: Tackling heterogeneity in biological samples 
 In-vitro biological research typically relies upon two types of human and mammalian 
tissue samples: cultured cell lines and primary cells sampled directly from an organism. While 
studies of primary cells are likely to be the most biologically relevant39–41, cultured cell lines 
are often more uniform in nature and are significantly easier to obtain. Primary cell samples 
are typically more difficult to culture, highly variable in size and mixed in composition. Due 
to being sampled directly from living tissue, primary samples typically contain cell types from 
multiple tissues of origin including muscle, vascular and immune cells. This complicates many 
traditional biological assays which rely on pooling analytes extracted from large numbers of 
cells. 
 Several strategies exist for tackling heterogeneous biological samples, but most can be 
broadly classified into two approaches: divide and conquer. ‘Divide’ approaches typically rely 
on cell sorting techniques to purify or enrich target cell populations from a sample while 
‘Conquer’ approaches utilize markers of cellular identity to track target populations within a 
mixed sample. Each approach has its limitations and advantages as well as a wide variety of 
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implementations. Some strategies and technologies that fall under this classification scheme 
will be discussed in greater detail in the following sections. 
1.2 Divide: Cell Sorting 
1.2.1 Manual manipulation 
 A variety of techniques for manual cell sorting have been developed of which two 
remain in common usage: limiting dilution and colony picking. Limiting dilution involves the 
serial dilution of a cell suspension and then separation of that suspension into aliquots of a size 
determined to maximize the probability of yielding only one cell per aliquot. The dilution and 
aliquoting process is a counting problem and thus well described by a Poisson distribution42. 
The Poisson distribution is shown in equation 1.1 where x is the expected number of cells per 
aliquot and lambda (λ) is the average number of cells per aliquot. 
ሺ1.1ሻ							Prሺݔ ൌ ݇ሻ ൌ 	ߣ
௞݁ିఒ
݇!  
Based on this relationship, the probability that x = 1 is maximal when λ = 1 and is 36.79%. As 
a result, this process is inefficient with an additional 36.79% of aliquots expected to contain 0 
cells and the remaining 26.42% of aliquots expected to contain >1 cell and therefore potentially 
be an impure mixture. Increased yield can thus only be achieved by increasing the number of 
replicates or the number of wells seeded in the case of limiting dilutions. For macroscale well 
plates, this significantly increases the reagent consumption and labor cost of cell isolation by 
limiting dilution. Additionally, the error rate inherent in the random dilution process requires 
that each aliquot be inspected to verify that only a single cell was collected and that the cell 
belongs to the targeted population. For example, isolating 100 cells from a mixture in which 
the target cell consists of 10% of the total population would require the generation of an 
average of 2,718 aliquots or 29 96-well plates and consume 543.6 mL of cell culture media.  
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 Colony picking and cloning rings are closely related approaches in which a dilute 
suspension of cells is seeded onto a cell-culture substrate and allowed to proliferate into clonal 
colonies. The colonies must be tracked closely during this proliferation to identify adjacent 
colonies which may have merged and are no longer pure or clonal in nature. Once colonies 
have been established, clones of the target cell type can be manually collected by scraping or 
pipetting and transferred onto separate culture surfaces for further expansion or analysis. 
 Taken together, manual cell isolation techniques are labor intensive and limited in 
throughput. They allow for a broad selection of criteria that can be used in determining the 
identity of target cells including cell surface staining, cell morphology, dynamic cell 
phenotypes and, if colonies can be readily split, gene expression or cell-internal staining after 
fixation. For many difficult cell separation problems, such as the isolation of single circulating 
tumor cells10 and genetically engineering stem cells43–45, limiting dilution and colony picking 
remain the gold standards for sorting. 
1.2.2 Fluorescence Activated Cell Sorting (FACS) 
 The flow cytometer revolutionized the study of single cells by introducing the ability 
to rapidly sort cells based on the simultaneous measurement of large numbers of fluorescence 
indicators46. In flow cytometry, flow focusing narrows and centers the flow of a suspension of 
single cells within a flow cell. One or more lasers or arc lamps are used to excite fluorophores 
internal to or bound to the cells and the fluorescence emitted and light scattered by individual 
cells is collected as they pass through an observation point and measured using photomultiplier 
tubes (PMTs)46. The use of laser excitation and PMT-detection provides flow cytometers with 
high sensitivity. Using multiple excitation sources and cross-channel fluorescence 
compensation, >20 optical parameters can be monitored simultaneously, allowing for very 
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high levels of label multiplexing47. Based on user-provided thresholds in multiple channels, 
target cell populations can be identified to trigger a downstream sort as described below. 
 The use of fluorescence measurements to trigger cell sorting is referred to as 
Fluorescence Activated Cell Sorting (FACS). The most common method for sorting cells 
passing through a flow cytometer involves the agitation of the flow cell with ultrasonic 
vibrations, breaking the sheath and core liquid flows into discrete droplets48. By synchronizing 
droplet generation with the sample flow rate, droplets containing individual targeted cells can 
be charged upon passing through a ring electrode and then deflected into collection wells by 
charged plates. This process can be highly sensitive to calibration, however, and target cells 
are often missed or doublets can be collected49–51. The effects of this are particularly evident 
when attempting to sort very small starting samples of cells and performance degrades rapidly 
when sorting samples smaller than 105 cells52. 
 While FACS remains the gold standard for high throughput live cell sorting, several 
key limitations are of note. The use of bulk fluorescence or light scattering readouts limits the 
criteria that can be used to select cells to be sorted to non-toxic membrane permeable dyes, cell 
surface markers that can be labeled with antibodies and bulk optical properties such as scatter 
and absorbance. Additionally, each cell can only be interrogated once as it passes through the 
observation window, a time period typically on the order of microseconds46, making it 
impossible to collect dynamic information about single cells let alone to sort based on those 
dynamic measurements.  
1.2.3 Magnetic-Activated Cell Sorting (MACS) 
 MACS is a far younger technology than FACS, with its first incarnation described in 
1990.53 MACS is a passive sorting modality in which cells are functionalized by biotin-labeled 
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antibodies which can then bind streptavidin, allowing biotin-coated magnetic nanoparticles (on 
the order 0.1 µm in diameter) to be attached to the cell through the streptavidin linker. The 
functionalized cells can then be either enriched by positive selection or depleted by negative 
selection by passing through a magnetic column. The use of either approach depends strongly 
on the prevalence of the target cell population as when the target cell population is sufficiently 
abundant, depletion of non-target cells can be achieved with rates of up to 1,000-fold while 
positive enrichment is possible up to 100-fold due to non-specific binding of nanoparticles and 
interactions between the cells and the magnetic column.53 
 Utilization of a passive enrichment approach dramatically simplifies the 
instrumentation required for enrichment, however MACS is limited relative to alternative 
sorting technologies in several critical manners. First, each selection step is limited to a single 
bulk enrichment based on the presence or absence of magnetic nanoparticles and therefore is 
incapable of performing selection based on the presence or absence of multiple markers. The 
use of antibody binding also limits the selection of labels to cell surface markers for which 
antibodies (or more recently, aptamers54,55) exist. Furthermore, as the enrichment occurs in 
bulk solution, isolating single cells requires subsequent isolation by an additional sorting 
technology. 
 While effective as an enrichment tool, the purity and yield of MACS suffers with very 
small initial samples52 and with samples containing target cells at very low concentrations.56 
Despite these limitations, its simplicity and ability to rapidly process large sample volumes has 
made it a popular enrichment technique in immunology57–60 and the study of circulating tumor 
cells (CTCs).61–65 In fact, CellSearch™ (Janssen Diagnostics, LLC), the only currently FDA-
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approved platform for CTC enrichment, relies on MACS to enable detection and enumeration 
of CTCs. 
1.2.4 Microfluidic platforms for cell sorting 
 A tremendous variety of microfluidic platforms have been developed for the 
manipulation, sorting and enrichment of mammalian cells. These platforms can be broadly 
categorized into three families: traps, microfluidic FACS and arrays. While many systems have 
been developed and demonstrated in the literature for microfluidic sorting of single cells, only 
one platform is currently commercially available, the C1™ single-cell auto prep system by 
Fluidigm Corporation, which utilizes a fluidic trap to capture individual cells for analysis by 
polymerase chain reaction (PCR).66 Array-based sorting platforms will be discussed in detail 
in Section 1.4. Of note is that these sorting modalities are not mutually exclusive and 
technologies have been demonstrated which employ a combination of approaches to achieve 
rapid and reliable cell separations.67 
 Trap-based systems for microfluidic cell sorting typically make use of one of two basic 
formats: filters and fluidic traps. Microfluidic filters function by physically or biochemically 
separating cell types based either on intrinsic properties of the cell such as size68,69 or 
biochemical properties such as the presence of unique surface markers.70–72 Fluidic traps 
instead rely on the physical separation of cells in continuous flow by biophysical means, taking 
advantage of differences in size67 or dielectric permittivity73–75 to achieve spatial separation in 
the context of fluid flow. 
 Physical trap based systems include hole76–78 and post arrays79 which separate cells 
based on size. These systems typically support high flow rates as they are very scalable and 
the maximum throughput of the trap is dependent upon the cross-sectional area of the trap 
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array, but have a tendency to clog. Biological samples are often not monodisperse in size and 
trap based systems typically suffer from poor purity80 as a consequence. Recent developments 
in inertial focusing of flowing cell suspensions have mitigated some of these limitations, 
however, allowing for continuous flow filtration to occur without clogging.81 These systems 
rely on the tendency of larger particles to interact with obstacles to induce a lateral 
displacement of particles that is size-dependent.82 Purity remains a concern and typically 
requires a second selection step67, however size based sorting can be achieved at high flow 
rates without clogging.67  
 For sorting applications in which size is not a sufficiently good marker for the target 
cell population of interest, biochemical means for separation are typically employed. The 
simplest form of biochemical selection of cells involves the use of a functionalized surface that 
the target cell has a specific affinity for. While this has most commonly been implemented in 
the form of antibody functionalized surfaces70–72,80, less specific surface interactions can be 
utilized for selection.83 Performance of biochemical surface capture devices is typically limited 
by the affinity of the functionalized surface, the flow rate through the device and the frequency 
of interactions between the functionalized surface and the flowing sample. In microfluidic 
channels where laminar flow dominates, it is frequently the interaction between the sample 
and the surface that is the limiting factor. Several strategies have been explored to maximize 
interactions with functionalized surfaces including post arrays to increase the functionalized 
surface area and to increase the probability of cells colliding with a surface80, nanoporous 
substrates which allow for flow perpendicular to the capture surface to be induced70 and 
grooves in the capture surface to induce cell rolling84.  
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 Two primary biophysical methods of sorting cells have been widely demonstrated in 
the literature: density-dependent inertial sorting and dielectrophoretic sorting. The most 
common inertial microfluidic sorting approach relies upon Dean drag forces that occur in 
laminar flow through curved microfluidic channels which acts to orient larger particles along 
the inner channel wall while smaller particles remain in the core of the flow profile85. 
Dielectrophoretic sorting relies on differences in the electrical permittivity of differing cell 
types to sort cells by exposing a sample flowing through a microfluidic channel to a non-
uniform electrical field, typically achieved by applying alternating voltages across the channel 
through multiple paired electrodes.73–75 The non-uniform field generates forces on particles 
within the fluid-filled channel by electrically polarizing the particle in an orientation which 
depends on the relative polarizability of the particle and the surrounding fluid. While 
dielectrophoretic and inertial flow-based sorting systems allow for rapid, continuous sorting of 
sample streams, both require the presence of significant differences in the biophysical 
properties of the target cell population relative to non-target cells. 
1.2.5 Sorting by imaging cytometry 
 Only a small number of integrated sorting platforms based on imaging cytometry have 
been demonstrated. The most commercially successful of these platforms is a technology 
termed laser capture microdissection (LCM) in which selected regions of a tissue slice can be 
dissected from its surrounding and isolated for further analysis. LCM remains the most 
commercially successful image based sorting platform available today. While several variants 
of the core technology platform exist, most follow a similar procedure for analysis and sorting. 
Typically, LCM begins by imaging stained tissue samples (most often fixed, but live tissue 
dissection techniques are now available86–88) and identifying regions of interest based on 
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colorimetric or fluorescent staining. The name LCM refers to the subsequent dissection process 
in which targeted regions of the tissue sample are dissected from the surrounding tissue by 
cutting the targeted region using an IR or UV laser and removing the dissected tissue with one 
of three methods.  
The first method makes use of an adhesive film which is pressed onto the dissected 
tissue slice and removed, taking the dissected tissue portions with it.89 While the simplest 
approach, it is also most non-specific as removal of the adhesive film can also remove loose 
material from non-dissected regions of the tissue sample. The second LCM extraction 
technique directly utilizes the dissection laser to melt a plastic film backing onto targeted 
regions of the tissue sample.89 This approach improves the specificity of tissue removal but the 
heating process risks degradation of critical analytes in the sample such as nucleic acids.  
The third approach makes use of one a physical separation that does not require direct 
contact of a removal surface to the tissue sample. These include gravity-assisted 
microdissection and laser pressure catapult.90 Other variants have been developed and are 
commercially available but will not be discussed here, more comprehensive reviews of LCM 
variants have been published widely.90–95 Gravity assisted microdissection makes use of a free-
standing thin film substrate onto which the tissue sample is mounted. Targeted regions of the 
tissue sample can be entirely released from the rest of the tissue by cutting through the substrate 
around the targeted region and allowing it to fall into a collection dish due to gravity. Laser 
pressure catapult systems work by a similar mechanism but an additional rigid substrate is 
placed beneath the thin film. A single laser pulse is fired beneath the dissected region after it 
has been dissected, catapulting the sample into a collection vessel against gravity.  
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The ability to sort live cells based on LCM has been a relatively recent development, 
albeit a powerful one. LCM has proven to be the first widely available platform to enable 
sorting based on image-based measurements on single cells, although it is not without its 
limitations. The mechanical and thermal stresses that occur during the microdissection and 
separation steps can result in reduced viability in sorting single cells.86,96 Additionally, sorting 
throughput is reduced by the time required to write a laser path around each target cell while 
avoiding neighboring cells. 
1.3 Conquer: single-cell analysis 
1.3.1 Advances in cytometry 
 Flow cytometry has significantly increased the throughput and content of single-cell 
analysis but remains limited in several key aspects. While the use of antibody-based staining 
allows the identification and isolation of cells based on surface markers, many phenotypes of 
interest to medicine and biology are not specifically identified by surface markers. In addition, 
the hydrodynamic forces experienced by cells during flow sorting places stress on adherent 
cells, particularly a concern for mechanosensitive stem cells. The requirement that cells be 
analyzed in suspension at a single time-point prevents the measurement of parameters 
requiring spatial and temporal resolution. 
 Partially in response to these limitations of flow cytometry, cytometry modalities were 
developed based on traditional fluorescence microscopy30,97,98 and laser scanning confocal 
microscopy99–101. In imaging cytometry, a motorized microscope capable of automated XYZ 
sample control is used to scan traditional tissue culture formats including slides and well-
plates, measuring fluorescence on an image sensor, typically a charge coupled device (CCD). 
Images can then be segmented and classified based on a variety of parameters including multi-
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channel fluorescence data and morphology. In laser scanning cytometry (LSC), an excitation 
laser is swept over a sample within each field of view of a microscope and fluorescence at each 
position within the field of view is measured by PMTs.99 The current output of each PMT is 
mapped to the intensity of an image based on the position of the laser point at the time of 
acquisition and thus an image is generated. The use of a laser excitation source and PMT 
detectors drastically increases the sensitivity and dynamic range of fluorescence measurements 
in LSC but also increases instrument complexity and cost relative to the use of arc-lamp 
excitation and image sensors for detection in fluorescence microscope.  
 LSC systems occupy a middle-ground between fluorescence microscopy and flow 
cytometry: increasing throughput over microscopy through automation while enabling more 
sophisticated analyses than is possible by flow cytometry. Only flow cytometry, however, is 
currently capable of sorting cells based on positive selection criteria. In positive selection, 
targeted cells are extracted from a mixed population. In contrast, negative selection involves 
the removal of off-target cells from a mixed population. For relatively rare cell populations of 
interest, positive selection is significantly more efficient than negative selection as it requires 
the identification and selection of a smaller total number of cells.  
 Dramatic advances in camera technology and the computational power of desktop 
computers combined with increased access to computer-controllable microscope frames have 
made quantitative and automated fluorescence microscopy increasingly accessible to 
researchers. In addition, several open-source software development initiatives have provided 
the groundwork for researchers to develop sophisticated automated imaging and image 
analysis solutions with relative ease. The Micro-Manager libraries provide a unified 
application programming interface (API) for controlling a wide variety of microscope bodies, 
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cameras, stages and accessories102, while tools like ImageJ103 and CellProfiler104 provide 
sophisticated image analysis capabilities without the need for researchers to produce their own 
implementations of image segmentation, tracking and classification algorithms.  
 In addition to ready access to instrumentation, imaging cytometry brings several key 
advantages over competing cytometry platforms to biomedical research. Live-cell imaging 
combined with automated analysis allows for the collection of rich multi-parametric dynamic 
measurements at single-cell resolution.97,105,106 This enables the simultaneous tracking of 
diverse populations of cells over time, enabling both temporally and spatially resolved 
measurements to be acquired within a mixed population. Such measurements are not possible 
with flow cytometry. There remain, however, several major limitations to unconstrained cell 
tracking by imaging cytometry. While advances in access to increased computational power in 
desktop computers have increased the ease with which complex image analysis tasks can be 
performed, the tremendous amount of data that can be produced by time-lapse imaging can 
still pose a significant bottleneck for image analysis. Additionally, while a larger set of 
measurements can be drawn from image cytometry data than other cytometry modalities, only 
a few attempts to enable sorting from image cytometry platforms have been commercially 
successful.107,108  
1.3.2 Continuing challenges in single-cell analysis 
 While imaging and flow cytometry modalities have significantly advanced single-cell 
analysis, only a limited set of assays can be performed with the optical readouts necessary for 
cytometric analysis. Clonogenic assays are challenging even when optical readouts are 
possible due to the computational cost and complexity of detecting mitosis and tracking 
daughter cells when imaging on conventional tissue culture substrates. Single cell sorting by 
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flow cytometry remains a challenge for small samples (<106 cells) as purity and yield can be 
inconsistent and requires that sorts be verified before destructive single-cell assays are 
performed. As a consequence, three critical opportunities exist for high-impact applications of 
cytometric and sorting technologies: 
1. Efficient and automated sorting of exceedingly small samples <104 cells would 
simplify the handling and analysis of a variety of primary cell samples from patient 
biopsies and small animal models. 
2. Rapid, simple and massively parallel clonogenic assays would enable a new generation 
of investigations into single-cell heterogeneity. 
3. Reliable, intrinsically verified single-cell separations would simplify analysis pipelines 
for a number of single-cell molecular assays including genome sequencing, 
transcriptome sequencing, PCR and chemical cytometry among others. 
1.4 Micropallet arrays  
 Micropallet arrays are a promising technology for the study and manipulation of single 
cells and cell colonies. Micropallets are arrays of pedestals fabricated on a substrate (typically 
glass) by conventional ultraviolet (UV) photolithography.109 UV photolithography allows for 
a wide variety of materials110,111, geometries and functional variations112–118 to be produced 
with well-established chemistries and hardware. The array substrate can readily be treated to 
be hydrophobic, causing air bubbles to be trapped between the micropallets upon immersion 
in aqueous solutions such as cell culture media.119 These bubbles prevent cells from migrating 
between micropallets and can be sustained for up to 7 days for long-lasting experiments. 
Individual elements from micropallet arrays can be released from the substrate by focusing a 
nanosecond-duration laser pulse at the interface between the glass and the photoresist through 
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a high numerical aperture (N.A.) lens. The release process is rapid, occurring in 
microseconds120, and can sort sensitive primary121 and stem cell122 populations with high yield 
and high viability. 
1.4.1 Micropallet array fabrication 
 Micropallet arrays were first fabricated using the epoxy-based photoresist SU-8109. SU-
8 was initially chosen for its ability to produce high aspect ratio structures, but its high 
autofluorescence and poor biocompatibility led to the development of an alternative, based on 
the Epon resin 1002F123. 1002F improved significantly on SU-8 in autofluorescence and 
biocompatibility, at the cost of a reduced maximum achievable aspect ratio (4:1). Basic 
micropallet array fabrication occurs in 5 steps as shown in Figure 1.1 below. The basic process 
involves:  
1. A uniform film of the photoresist is generated on the substrate by spin-coating. 
2. Solvent is removed from the film by a ‘soft-bake’ at 95 °C for a duration determined 
by the thickness of the film. 
3. The film is exposed to long-wave UV light (>360 nm) through a patterned chrome 
mask with a total dose determined by the thickness of the film. 
4. The exposed regions of the film are cross-linked by heating to 95 °C for 10 min. 
5. The uncrosslinked photoresist is removed by developing in 1-methoxy-2-propyl 
acetate. 
 Initial release experiments with SU-8 and 1002F-based micropallets required the 
micropallet array to be inverted over a collection dish so released micropallets could be 
collected by gravity.109,124 This approach introduced contamination from weakly adherent cells 
which could detach from the array and settle to the collection dish as well and motivated the 
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development of a transparent, magnetic photoresist which would allow for the collection of 
micropallets against gravity to improve the purity of sorting.111 This photoresist was 
challenging to synthesize, however, as it required high intensity ultrasonication in order to 
prevent the formation of macroscopic aggregates of the iron oxide nanoparticles used to impart 
magnetic properties to the photoresist and thus could only produce small quantities of magnetic 
photoresist at a time. This limitation motivated the work presented in Chapter 2 to develop a 
batch-scalable process for producing a transparent, biocompatible magnetic composite 
photoresist for micropallet array fabrication. 
1.4.2 Virtual air walls: clonal segregation on micropallet arrays 
 A critical consideration for micropallet arrays is the prevention of cell adhesion to the 
sidewall of the micropallet (detrimental to imaging), cell adhesion in the gap between 
micropallets (impossible to sort) and cell migration between adjacent micropallets (makes cell 
tracking difficult). This was achieved through the treatment of the micropallet array with a 
hydrophobic silane, (heptadecafluoro-1,1,2,2-tetrahydrodecyl)-1-trichlorosilane. When treated 
with the hydrophobic silane and immersed in aqueous solution, the micropallet array traps air 
in the gaps between micropallets, these air-filled gaps are termed ‘virtual air walls’119. The 
exceedingly hydrophobic surface coupled with the air liquid interface at the micropallet gap 
serves to prevent cell adhesion in and migration across the virtual air-wall, allowing each 
individual micropallet to be maintained as a clonally isolated culture site while allowing cells 
to share media and exchange soluble factors. The stability of the virtual air walls was shown 
to be a function of the gap width, side length and thickness of a micropallet array with square 
elements. The transition from Wenzel (homogeneous) to Cassie-Baxter (heterogeneous) 
wetting125 was observed to occur above a roughness factor (R) of 1.6 when calculated using 
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Equation 1.2 where b is the side length of the micropallet, a is the gap between adjacent 
micropallets and h is the thickness of the micropallet119. Additional factors that affect the 
stability of virtual air walls include the ionic strength (improves stability), surface tension 
(improves stability) and protein concentration (reduces stability) of the solution. 119 
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1.4.3 Micropallet release: Enabling sorting on micropallet arrays 
 Laser light, when focused through a high N.A. lens, produces strong electric fields 
within the focal volume which, if the field strength is sufficiently high, can result in bulk 
ionization therein.120 The resulting plasma, if confined as at the interface between two 
materials, produces a high pressure gas which can expand at the interface and disrupt the 
adhesion between the layers. This phenomenon is utilized to effect the release of micropallets 
from their glass substrate in a controlled fashion. By tuning the laser energy, individual 
micropallets can readily be released from the array with a single pulse without affecting the 
adhesion or viability of the target cell which is protected by the intervening bulk material of 
the micropallet. Sensitive stem cells such as primary canine myoblasts121 and murine 
embryonic cells122 have been sorted using this approach without inducing differentiation or 
cell death. 
1.5 Imaging and image analysis 
1.5.1 Noise and imaging 
The majority of the information presented in this section is well described in standard 
textbooks that discuss the fundamentals of image sensor operation as well as recent 
developments and their implications for microscopy and scientific imaging. The material 
herein is drawn from detailed discussions of image sensors and important considerations for 
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light microscopy from Fundamentals of Light Microscopy and Electronic Imaging.126 This 
section is intended as an overview of important considerations in the design of an imaging 
system for cytometry and is not meant to be an exhaustive treatment. Information found from 
other sources will be cited accordingly. 
 Noise, sensitivity, resolution and throughput are fundamentally interdependent and 
critical performance considerations in the design of an imaging cytometer. These parameters 
are a function of several physical components of the image sensor design of which two 
principal variants are most commonly utilized: interline charge coupled device (CCD) and 
complementary metal oxide semiconductor (CMOS) based cameras. There are three primary 
sources of noise in image sensors: dark noise, counting noise and readout noise.  
Dark noise is generated by charge accumulation due to thermally induced currents in 
the sensor. Dark noise is typically uniform across the sensor and increases linearly with 
exposure, allowing for its straightforward removal through the subtraction of a ‘dark frame’ in 
which no illumination or sample is present from each subsequent image. Dark noise is typically 
of little consequence in modern cameras, as it has been effectively eliminated in the majority 
of scientific cameras by actively cooling the sensor to reduce the thermal current build-up.  
Counting noise, often referred to as ‘shot’ noise, is a problem inherent to all light 
measurement and is caused by the discrete nature of light and charge. Since all light sensors 
are, in essence, counting photons by converting the energy of each incident photon into a 
charge, stochastic variations in the number of photons absorbed by each sensor pixel occur. 
These variations are described by the Poisson distribution whose probability mass function 
was shown in equation 1. A key feature of the Poisson distribution is that the variance of the 
distribution is equal to its mean. As a consequence, the standard deviation of photons for a 
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mean incident photon rate of µ will be √μ resulting in a decrease in the relative variation in 
photon counts as µ increases. From a practical standpoint counting noise can thus be decreased 
by collecting more photons. Three approaches can be employed to this end in cytometric 
systems: increasing illumination, utilizing more fluorophore or a fluorophore with higher 
quantum efficiency, or increasing the size of each detector element. Increasing illumination 
can be extremely effective but must be employed with caution as photobleaching and 
phototoxicity can become significant at high light fluence. Increasing the concentration of 
fluorophore also brings similar trade-offs as non-specific labeling and dye toxicity increase at 
high concentrations. Fluorophores such as fluorescein and rhodamine remain popular due to 
their low cost and well-characterized chemistries but suffer from relatively poor quantum 
efficiency and photobleach readily.127 A number of new dyes such as the Alexa Fluor family128 
and the boron-dipyrromethene (BODIPY) family129 of dyes have been developed with 
significant improvements in quantum efficiency, environmental stability and wavelength 
tunability. Similarly, advances in fluorescent protein engineering have resulted in large number 
of wavelength tunable and highly efficient variants130 of the original green fluorescent protein 
(GFP)131. 
Readout noise is common to all conventional image sensor architectures which make 
use of semiconductor-based amplifiers for image gain. High sensitivity flow cytometry was 
enabled in part by the development of the extremely low-noise, high-gain amplification process 
inherent to photomultiplier tubes (PMT). The operation of photomultiplier tubes is based on 
the photoelectric effect in which specially selected materials are highly efficient at converting 
incident photons into emitted electrons. In PMTs, a glass window to a vacuum tube is coated 
with such a material, referred to as the photocathode, and successively higher voltages are 
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applied between staggered electrodes termed ‘dynodes’. Photoelectrons emitted from the 
photocathode are accelerated by this voltage toward the first dynode and strike it with increased 
kinetic energy resulting in the release of additional electrons through secondary emission. Each 
successive dynode further accelerates each batch of secondary electrons resulting in successive 
amplification of the total photocurrent. The process is extremely efficient and can amplify 
current with gain up to 108. A similar semiconductor based approach to increasing low-noise 
gain in silicon photodiodes resulted in the development of the avalanche photodiode.132 While 
the avalanche gain process is subject to higher readout noise than PMTs, photodiodes benefit 
from a higher quantum efficiency, particularly at longer wavelengths. The integration of 
avalanche gain principle into an imaging sensor, termed the electron multiplying CCD (or EM-
CCD), was a major advance for low-light, high-speed imaging although it remains limited in 
resolution by the complexity of integrating the multi-stage avalanche gain mechanism on-
sensor. The majority of commercially available EM-CCD cameras support a pixel resolution 
of 512×512 (eg. Evolve 512, Photometrics Inc. iXon3 897, Andor Technology) pixels although 
high resolution models are available up to 1024×1024 pixels (eg. Cascade II, Photometrics Inc. 
iXon3 888, Andor Technology). By comparison the current generation of scientific CMOS 
(often referred to as sCMOS) sensor-based cameras are available at resolutions of up to and 
exceeding 2048×2048 pixels (eg. Orca-Flash4.0, Hamamatsu Photonics. Zyla 4.2 & Zyla 5.5, 
Andor Technologies). Imaging resolution is also a function of the performance and design of 
the imaging optics, thus an appropriate camera resolution must be selected that accounts for 
the required maximum resolution, operating magnification and diffraction-limited 
performance of the optical system utilized. 
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1.5.2 Automation of image analysis 
 While the development of novel methods for automated image analysis is not a focus 
of this dissertation, a number of commonly used methods and tools in automating the 
segmentation and tracking of cells in fluorescence images are used and warrant discussion. 
The majority of image segmentation problems discussed in this dissertation made use of the 
open-source CellProfiler package developed at the Broad Institute at the Massachusetts 
Institute of Technology.104 CellProfiler provides a set of configurable modules which can be 
chained together into processing pipelines and includes a number of common image 
processing, segmentation, tracking, and measurement algorithms. The core of CellProfiler’s 
image segmentation algorithm is one of the most common workflows in the segmentation of 
fluorescence images of cells and consists of two steps: threshold and declump.  
A wide variety of commonly used unsupervised thresholding algorithms have been 
exhaustively reviewed in the literature133,134, each with their own advantages and 
disadvantages. In this dissertation, however, the one most commonly utilized was Otsu’s 
method which attempts to cluster the pixels in an image into two or three classes by minimizing 
the variance of the pixel distributions within each class135.  Thresholding a fluorescence image 
containing cells accomplishes a key step towards identifying cell boundaries and locations by 
demarking pixels comprising the image background from cellular fluorescence. In cases where 
fluorescence intensities vary from cell to cell or background values vary over the image, no 
optimal threshold may exist which can efficiently identify every cell within an image without 
inadvertently merging cells in contact or close proximity. In such cases it becomes necessary 
to use additional data from the image to identify the boundaries that separate adjacent cells 
within foreground-classified pixels.  
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One of the best studied algorithms for achieving this is the watershed transform which 
identifies ridges in image data that surround local minima.136,137 The watershed transform can 
be used on a variety of measurements including the first or second order image gradient 
magnitude or object shape by computing the distance transform of thresholded foreground 
pixels. Each has its own advantages; the first order gradient watershed is most effective when 
there is sure to be a difference in image intensity at the boundary between adjacent cells, the 
second order gradient depends on the intensity of each cell decreasing as it approaches the 
boundary but is more sensitive to subtle differences in the magnitude of the intensity difference 
at the boundary and the distance transform is most effective when cells are of uniform shape 
and clusters are sufficiently sparse that curvature at cell boundaries is detectable in the 
thresholded image. 
The combination of a well-selected threshold and watershed approach can achieve very 
high degrees of accuracy in segmenting clusters of cells from fluorescence images.138 While 
algorithms exist which can improve performance beyond these levels, they typically come at 
the cost of significant increases in computational complexity and the difficulty of optimization. 
Well-trained shape models, for example, can achieve extremely high accuracies139,140 but can 
be challenging to implement in systems where cellular morphology can vary significantly from 
cell to cell as is the case in the in-vitro culture of  cancer cell lines and dramatically increase 
computational complexity.  
1.6 The scope of this dissertation 
 The work presented in this dissertation focuses on the development of an integrated 
imaging cytometry and cell sorting platform. Chapter 2 describes the development of a novel 
process for producing a magnetic photoresist to allow for the manipulation and micropallets 
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and other microstructures using externally applied magnetic fields and has been published in 
the Journal of Micromechanics and Microengineering. Chapter 3 focuses on the development 
of the software required to automate two critical elements in the development of an integrated 
micropallet array sorting imaging cytometer: the capability to automate the imaging and 
localization of cells on micropallet arrays and to automate the micropallet release process. A 
manuscript based on the work described in Chapter 3 has been prepared and submitted for 
review. While automated image analysis is used heavily throughout Chapters 3 and 4, neither 
the development of novel image segmentation and classification approaches nor the complete 
optimization of existing algorithms were a goal of this dissertation. This is a direct consequence 
of one of the key advantages of micropallet array-based imaging cytometry and the additional 
challenges which emerge as a consequence. The broadened cell selection criteria and complex 
assays that are possible to perform using micropallet arrays require the integration of basic 
repeated image analysis tasks with customizable data analysis approaches. To streamline the 
development of new applications, a general-purpose image analysis tool (CellProfiler104) was 
utilized to automate generalizable tasks which primarily consisted of image segmentation. 
Segmented images were then processed using MATLAB scripts as necessitated by the specific 
application or assay that was being performed. Chapter 4 extends the capabilities described in 
Chapter 3 to a massively parallel clonogenic screening application. The goal of this work was 
to characterize the evolution of a reporter cell line commonly used in high throughput screens 
for the study of the Wnt/β-catenin pathway. The emergence of heterogeneity in cancer cell 
populations is a poorly understood process, although one that has garnered significant interest 
due to its implication in the development of resistance to chemotherapy. The characterization 
of small clonal colonies provides relatively weak statistical power in comparisons due to the 
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inherently small sample sizes. In order to draw meaningful conclusions from such data a very 
large number of clones must be characterized, significantly larger than would be practical by 
limiting dilutions and conventional multi-well plate imaging. This application extends far 
beyond the capabilities of conventional cytometry modalities based on slide scanning or flow 
cytometry. This work has been prepared as a manuscript to be submitted for review. 
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1.7 Figures 
 
 
 
Figure 1.1. General fabrication scheme for micropallet arrays consisting of i. Generating a thin 
film of photoresist on a glass substrate by spin coating, ii. Soft baking the film to remove 
solvent, iii. Exposing the film to near UV light through a chrome mask pattern, iv. Baking the 
film to crosslink exposed portions of the film and v. Removal of uncrosslinked polymer by 
developing in 1-methoxy-2-propyl acetate. 
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Chapter 2 Scalable synthesis of a biocompatible, transparent and superparamagnetic 
photoresist for microdevice fabrication 
  
2.1 Introduction 
The generation of nanocomposite photoresists with modified properties has 
dramatically expanded the toolbox available for the integration of active and passive 
components into microdevices. Nanocomposites have been developed to confer properties of 
ferro- and superparamagnetism for mechanically actuatable devices1–5, conductivity for the 
integration of electrodes6–9, high dielectric constants for integrated capacitors10, low internal 
stress for improving mechanical properties11  and a low index of refraction for the generation 
of on-chip optical waveguides12. These composites have typically relied upon the addition of 
insoluble components, often nanoparticles, into the photoresist. A common feature among 
nanocomposites incorporating metallic colloids is reduced accuracy in reproducing mask 
features, diminished fabrication quality and poor optical clarity. This undesirable optical 
property is generally due to an uneven distribution of the colloid in the photoresist as a result 
of aggregation. For biological applications where optical clarity is critical for analysis and 
imaging, transparent nanocomposite photoresists would prove valuable. Gach et al1 
demonstrated a method for dispersing iron oxide nanoparticles in photoresist that yielded 
high-fidelity, optically clear structures. This method, however, required high-intensity 
ultrasonication to prevent nanoparticle aggregation and was not amenable to production in 
large batches. In addition, the resulting photoresist was limited to aspect ratios of 4:1, 
offering no improvement in mechanical properties over the native 1002F photoresist it was 
based upon.13 
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To address these issues, we present a novel photoresist composite incorporating the 
epoxide-based photoresist 1002F and poly(methyl methacrylate-co-methacrylic acid) 
(PMMA/MMA). To test the photolithographic performance of the PMMA/1002F-based 
photoresist, arrays of microposts of varying diameters were fabricated and imaged by 
scanning electron microscopy (SEM). The dispersion of the maghemite nanoparticles in the 
PMMA/1002F composite was evaluated by imaging 100 nm-thick sections of the cross-
linked composite by transmission electron microscopy (TEM). The spectral transmittance of 
the 0.25% (w/w) maghemite PMMA/1002F composite was measured by UV-Vis 
spectroscopy and the reaction of PMMA/MMA with the 1002F epoxy was confirmed by 
differential scanning calorimetry (DSC). The effect of the maghemite PMMA/1002F 
composite surface on cellular metabolism was tested by tracking the metabolic activity of 
HeLa cells over 72 h. Additionally, the compatibility of the composite surface with primary 
cell culture was evaluated by culturing murine mesenchymal stem cells for 72 h and 
observing cell morphology. The functionality of the magnetic composite was assessed by 
isolating single adherent cells cultured on an array of individually removable magnetic cell 
carriers.14,15 
2.2 Materials and Methods 
2.2.1 Synthesis of maghemite nanoparticles 
A solution of 10-nm maghemite nanoparticles in toluene was prepared using the 
method described by Gach et al.1 Iron salts (23.82 g FeCl2 and 38.94 g FeCl3 in 3 L of 
deionized (DI) water) were precipitated by the addition of a strong base (240 mL of 14.5 M 
NH4OH), and washed three times with DI water by magnetic decantation. After resuspension 
in 480 mL of 1.5 M HNO3, 104 g of Fe(NO3)2 was added to the solution which was then 
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heated to boiling for 1 h. After cooling to 25 °C the precipitate was again washed by 
magnetic decantation once with 480 mL of 1.5 M HNO3, once with 2500 mL of 0.1 M 
NH4OH and resuspended in 1500 mL of DI water. 90 g of oleic acid was added to the 
suspension and mixed for 15 minutes. The excess oleic acid and water were removed from 
the precipitate by three successive extractions with 200 mL of 100% ethanol. The precipitate 
was then dissolved in 800 mL of toluene and stored in amber glass bottles until use. 
2.2.2 Composite preparation 
Maghemite nanoparticles (3 g) were diluted with toluene (800 mL total volume). The 
weight percentage of maghemite nanoparticles in toluene was determined by evaporating 
solvent from a sample by heating at 120 °C for 30 min and weighing the dry solids. 
PMMA/MMA (100 g of methyl methacrylate:methacrylic acid at a molar ratio of 1:0.016, 
PMMA/MMA molecular weight =34,000, Sigma Aldrich, St. Louis, MO) was added to the 
nanoparticle solution and allowed to dissolve overnight while stirring. γ-butyrolactone (233.3 
g) was added drop-by-drop using a separatory funnel and stirred further for an additional 24 
h. The toluene in the solution was then removed by roto-evaporation at 60 C leaving a deep 
red, highly viscous polymer suspension. The superparamagnetic PMMA/MMA solution was 
then added directly to 1002F-50 photoresist (1:2.6 by mass, PMMA/MMA:1002F-50) which 
had been prepared as previously described.13 The mixture was then placed on a bottle roller 
for 4 days. The resulting PMMA/1002F photoresist was deep red in color. 
2.2.3 Characterization of PMMA/1002F photoresist and magnetic composite 
Melting point and glass transition temperatures were determined by DSC with a Q200 
calorimeter (TA Instruments, New Castle, DE). 1002F and PMMA/MMA samples were 
analyzed as pure powders packed into the DSC sample pans. The PMMA/1002F was 
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analyzed after 100 µL of the polymer suspension was baked into the sample pan at 120 °C 
for 72 h under vacuum to completely remove the solvent. For optical characterization, 50 µm 
thick films of 1002F photoresist, PMMA/1002F, and PMMA/1002F with 0.25% (w/w) 
maghemite nanoparticles were prepared by spin coating onto plasma-cleaned #2 glass 
coverslips. These films were treated as described below for micropallet fabrication before use 
except that no mask was used in producing UV-cross-linked films. Transmission spectra for 
triplicate preparations of each film were measured with a bare coverslip as a blank using a 
SpectraMax M5 spectrophotometer (Molecular Devices Corporation, Sunnyvale, CA). 
Working curves were generated by producing films of different thickness by varying the 
speed of the spin-coat step. The exposure needed to fully cross-link the films and form 
microstructures was then optimized and the final thickness of the film measured using a P-6 
stylus profilometer (KLA Tencor, Milpitas, CA). The maximum aspect ratio of the 
PMMA/1002F with 0.25% maghemite nanoparticles composite was determined by 
fabricating a post-array using the protocol described below for fabrication of micropallet 
arrays. The fabricated structures were then imaged by SEM using a Quanta 200 
environmental-SEM (FEI, Hillsboro, OR). The dispersion of maghemite nanoparticles into 
the PMMA/1002F photoresist was characterized by imaging transverse slices of a 50-µm 
thick film of the magnetic PMMA/1002F composite photoresist by TEM (JEOL 100CX II). 
The film was set in Polybed 812 resin and cured at 65 °C overnight. 100 nm thick sections of 
the film were cut with an ultramicrotome prior to imaging. 
2.2.4 Cell culture and proliferation assay 
Uniform films of PMMA/MMA, 1002F-50 and PMMA/1002F with 0.25% (w/w) 
maghemite nanoparticles as well as bare glass slides were treated with an air plasma (Harrick 
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Plasma, Ithaca, NY) for 5 min after being affixed to 4-well arrays fabricated from polylactic 
acid (PLA) with a benchtop 3D-printer (BFB-3000, Bits from Bytes Inc., Clevedon, UK). 
Polydimethylsiloxane (PDMS) was used to glue the wells to the surfaces.  HeLa cells were 
plated in 3 of 4 wells of each array at a density of 2000 cells per well in 100 µL of culture 
media and cultured for 24, 48 or 72 h. Medium in each well was replaced every 24 h. A 
standard cell proliferation assay (MTT) was performed at multiple time points in accordance 
with the manufacturer’s instructions (Life Technologies, Grand Island, NY). Briefly, 10 µL 
of 5 mg/mL (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was 
added to each of 3 sample wells and one control well containing no cells and incubated at 37 
º C for 4 h. MTT is metabolized by cells into an insoluble purple formazan which is then 
solubilized by the addition of 100 µL of 100 mg/mL sodium dodecyl sulfate (SDS) in 0.01 M 
HCl followed by incubation at 37 ºC for 4 h. 100 µL of fluid from each well was sampled 
and absorbance measurements were taken at 570 nm using a spectrophotometer. To test the 
compatibility of the composite with primary cell growth, mesenchymal stem cells (MSC) 
were derived from the long bone of a mouse14 and plated on conventional tissue-culture 
dishes or films of the magnetic PMMA/1002F composite in Dulbecco’s Modified Eagle 
Medium (DMEM) with 10% fetal bovine serum and cultured for 72 h. 
2.2.5 Single-cell isolation by magnetic micropallet release 
Micropallet arrays were fabricated according to previously reported protocols.14-17 A 
70 µm thick film of PMMA/1002F 0.25% (w/w) maghemite nanoparticles was spin coated 
onto 75×25 mm glass slides. The solvent was evaporated from the film by baking in a 95 °C 
oven for 60 min. The PMMA/1002F with 0.25% (w/w) maghemite nanoparticles required 7× 
higher exposure energies to fully cross-link the polymer as compared to similar features 
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fabricated in native 1002F-50. Fabricated arrays were then treated with air plasma for 5 min 
prior to coating the arrays by low-pressure vapor deposition of (heptadecafluoro-1, 1, 2, 2-
tetrahydrodecyl)trichlorosilane as previously described.15  
The micropallet array was then glued with PDMS onto a cassette fabrictated from 
acrylonitrile butadiene styrene (ABS) by means of a 3-D printer. The PDMS was cured in a 
70 °C oven for 30 min. Prior to use, the array was sterilized by rinsing with 70% ethanol and 
air-drying under a germicidal UV lamp for 30 min. The surface of the micropallet array was 
coated with fibronectin by incubating the array in 1 mL of 25 µg/mL fibronectin in 
phosphate-buffered saline (PBS) for 30 min at 25 °C. The array was then rinsed 3 times with 
PBS and finally immersed in Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal 
bovine serum. A suspension of HeLa cells expressing GFP (10,000 cells in 3 mL) was added 
to each cassette and the cells were allowed to settle and adhere to the pallets overnight. The 
cells were imaged the following day, and cultured on the micropallet array for 2 additional 
days to allow clonal colonies to form. Prior to release, the micropallet cassette was mated to 
the bottom of a 47 mm diameter Petri dish (BD Biosciences, San Jose, CA) which had been 
treated with air plasma for 10 min and sterilized using the protocol described above. The 
magnetic collection experiment was carried out as described by Gach et al.1 The clonal 
colonies were released by focusing a 5 ns pulse from an Nd:YAG laser at the photoresist-
glass interface through a 20× , 0.7 N.A. objective and collected against gravity by a ring-
shaped rare earth magnet (K&J Magnetics) placed on the collection plate. The cassette was 
designed to reduce the gap between the array and the collection plate to 3 mm. After 
collection, the Petri dish was removed from the cassette with the magnet, inverted and filled 
with an expansion media consisting of 50% FBS, 25% HeLa-GFP conditioned DMEM and 
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25% fresh DMEM. The conditioned media was generated by incubating 20 mL of fresh 
DMEM on a culture of HeLa cells on a 75 mm2 tissue culture flask at 50% confluency for 24 
hours. The conditioned media was then aspirated and filtered through a 0.22 µm nylon filter 
and stored at 4 °C for less than 72 h before use. The released clonal colonies were imaged 
again after 3 days to confirm their viability and to observe the expansion of the colony onto 
the Petri dish surface. 
2.3. Results 
2.3.1 Characterization of PMMA/1002F photoresists 
Previous protocols to stably disperse maghemite nanoparticles into pure 1002F 
photoresist proved difficult to scale. Polymer additives were explored for their potential to 
stabilize the maghemite nanoparticles while forming a single phase with the photoresist. 
PMMA/MMA was selected as an additive to the 1002F photoresist system for its optical 
clarity, high glass transition temperature and the presence of acidic groups which could react 
with epoxides in the 1002F as well as stabilize the nanoparticles. The glass transition of 
PMMA/MMA occurred at 110 °C (Figure 2.1A). Un-crosslinked 1002F was observed to 
melt at 56.8 °C. When a mixture of PMMA/MMA and 1002F was heated from 40 °C to 140 
°C, the material did not melt and a single glass transition was observed at 110 °C, supporting 
the conclusion that covalent bonds were formed between the 1002F and PMMA/MMA to 
form a single phase. 
 In order to maintain optical clarity for imaging and photolithographic fidelity, 
maghemite nanoparticles <20 nm in diameter were used to generate a magnetic photoresist. 
Oleic acid-capped nanoparticles rapidly aggregated when mixed directly into the GBL-based 
solutions of PMMA/MMA or 1002F and cured (Figure 2.1C). To prevent particle 
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aggregation during solvent mixing, the PMMA/MMA was initially dissolved in toluene 
followed by addition of nanoparticles in the same solvent.  GBL was then slowly introduced 
into this toluene-based solution. The magnetic nanoparticles remained dispersed in the 
solvent mixture and after evaporation of the toluene leaving the PMMA/MMA and 
nanoparticles dissolved in GBL alone. The PMMA/MMA/nanoparticle solution was then 
mixed into a solution of 1002F with GBL as the solvent. The nanoparticles showed no visible 
aggregation or phase separation after the composite photoresist was cured when examined by 
light microscopy (Figure 2.1D). When viewed by electron microscopy, the cross-linked 
magnetic PMMA/1002F composite possessed nanoparticle aggregates of 200 nm or less 
(Figure 2.1E). When examined by spectrophotometry, the cross-linked photoresist remained 
transparent at visible wavelengths greater than 500 nm (Figure 2.1B). The marked 
absorbance increase in the UV wavelengths resulted in a 4-fold increase in the exposure dose 
required for photolithography of the nonmagnetic PMMA/1002F photoresist and a 7-fold 
increase relative to that of 1002F photoresist. The 0.25% (w/w) maghemite PMMA/1002F 
composite showed no signs of visible aggregation or flocculation after more than 6 months of 
storage at room temperature in an amber glass bottle. The magnetic PMMA/1002F composite 
was produced in batches as large as 1 kg. 
2.3.2 Photolithographic performance of PMMA/1002F photoresists 
Previous reports of 1002F-based photoresists demonstrated an aspect ratio of 4:1.14 
Higher aspect ratios up to 20:1 have been demonstrated for SU-8, a related photoresist.18 The 
maximum aspect ratio achievable by conventional UV photolithography with the 
PMMA/1002F photoresist was evaluated by preparing films of varying thickness and 
optimizing the total UV exposure energy through a test pattern containing circular holes 
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ranging from 1 to 10 µm in diameter. When circular posts were fabricated, the PMMA/1002F 
composite with 0.25% (w/w) maghemite nanoparticles provided aspect ratios exceeding 10:1 
(Figure 2.2C). The maghemite nanoparticle content of 0.25% (w/w) was selected as it was 
previously determined as the minimum weight percentage required to reliably collect release 
micropallets from a distance of greater than 2 mm.1 The smallest feature successfully 
produced in these photoresists was 4 µm, the smallest diameter tested and a reasonable size 
limit for bioanalytical microdevices. The features shown (Figure 2.2C and D) were fabricated 
3 months after the initial preparation of the maghemite PMMA/1002F composite 
demonstrating the long-term stability of the photoresist. The PMMA/1002F composite has 
been utilized with no apparent loss in performance up to 1 year after the initial preparation of 
the photoresist, comparable to the shelf life of commercially available SU-8 photoresist (13 
months). 
2.3.3 Cell culture on PMMA/1002F photoresist surfaces 
Biocompatibility is an important consideration in selecting materials for fabricating 
microdevices for biological applications.19,20 Data in the literature suggests that iron oxide 
nanoparticles can be cytotoxic.21,22 A series of metabolic assays using MTT were performed 
over a 72-h period to assess the effects of the magnetic PMMA/1002F composite and its 
various components on cell growth and metabolism. Three substrates were prepared from 
each of the following, PMMA/MMA, PMMA/1002F, PMMA/1002F with 0.25% (w/w) 
maghemite particles, 1002F, and untreated glass. An MTT assay was performed on HeLa 
cells cultured on the substrates at 24, 48 and 72 h after seeding (Figure 2.3A). The 
PMMA/1002F with nanoparticles showed no statistically significant (α = 0.05) effect on the 
growth and metabolism of these cells relative to a glass surface. Additionally, mesenchymal 
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stem cells (MSC) derived from murine long bone grown on films of the magnetic 
PMMA/1002F composite displayed typical morphologies compared with that exhibited by 
cells grown in conventional tissue-culture dishes (Figure 2.3B).  
2.3.4 Single-cell isolation using magnetic micropallet arrays. 
Recent improvements in the sensitivity of molecular assays and growing recognition 
of the importance of heterogeneity in biological systems have highlighted the need for 
parallel improvements in single-cell isolation platforms.23 Micropallet arrays have been 
demonstrated as an efficient platform for performing single-cell isolation from samples of 
varying size and diversity.15-17 The use of a transparent, magnetic photoresist in the 
fabrication of micropallet arrays enables the facile collection of cells, preventing 
contamination with undesired cells and allowing multiplexed isolation by collecting released 
micropallets into microwell arrays.1 
A cassette for single-cell isolation was developed by mating micropallet arrays 
fabricated superparamagnetic PMMA/1002F with polystyrene Petri dishes (Figure 2.4A). 
The upper lid of the Petri dish was used as a pallet-collection plate (Figure 2.4A). HeLa cells 
stably expressing a histone-H2B-GFP fusion protein were seeded onto an array of 
superparamagnetic micropallets (200 elements X 200 elements) coated with fibronectin, 
incubated at 37 °C overnight, and imaged (Figure 2.4B). After 2 d in culture, the individual 
cells expanded into clonal colonies on each micropallet (Figure 2.4C). After laser-based 
release, Selected micropallets with cells were released by a laser (n=5) and then collected 
onto the Petri dish lid by application of a magnetic force. The isolated colonies were 
followed over time and 100% of the colonies continued to proliferate with increased cell 
numbers (Figure 2.4D).  
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2.4. Conclusions 
A highly scalable process for producing transparent, magnetic photoresist was 
developed enabling kilogram-sized batches to be synthesized. The resulting magnetic 
composite photoresist was capable of forming microstructures with aspect ratios greater than 
10. Microstructures formed from the magnetic composite photoresist were highly transparent 
in the visible spectrum, were compatible with conventional fluorescence imaging and 
mammalian cell culture (including primary cell culture) and were used to fabricate 
magnetically active structures with demonstrated applications in single-cell isolation. The 
excellent optical and biological properties of the magnetic composite photoresist demonstrate 
its potential value for a wide variety of applications such as cell manipulation, the production 
of magnetic meta-materials, and fabrication of magnetically actuatable microsystems. 
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2.5 Figures 
 
 
Figure 2.1 Properties of PMMA/1002F (A) Heat flow curves of PMMA/MMA (dashed line), 
1002F (dotted line) and PMMA/1002F (solid line) photoresist as measured by differential 
scanning calorimetry while heating at a rate of 10 °C/min. The curves for PMMA/MMA and 
PMMA/1002F photoresist have been offset by 3 and 4.5 W/g, respectively. (B) Absorbance 
spectra of 50-µm thick films of PMMA/MMA (solid line), PMMA/1002F (dashed line) 
photoresist and PMMA/1002F with 0.25% (w/w) maghemite nanoparticles (dotted line). 
(C,D) Optical micrograph of a cured film produced from the direct addition of maghemite 
nanoparticles into 1002F photoresist (C) and of a film of PMMA/1002F with 0.25% (w/w) 
maghemite nanoparticles (D). The scale-bar is 50 µm. (E) TEM of a transverse slice of a 
cured film of PMMA/1002F with 0.25% (w/w) maghemite nanoparticles. The scale-bar is 
100 nm. 
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Figure 2.2. SEM micrographs of microstructures fabricated from PMMA/1002F photoresists. 
(A) Working curve showing required UV dose to cross-link films of PMMA/1002F with 
0.25% (w/w) maghemite nanoparticles of varying thicknesses. (B) Relationship between spin 
speed and film thickness of PMMA/1002F with 0.25% (w/w) maghemite nanoparticles (N=3, 
error bars not visible). (C) Micropost (6×72 µm, diameter×height, aspect ratio = 12) 
fabricated from PMMA/1002F photoresist with 0.25% (w/w) maghemite nanoparticles. The 
scale-bar is 6 µm. (D) Arrays of micropallets (100×100×50 µm, L×W×H). The scale-bar is 
10 µm.  
D 
A 
C 
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Figure 2.3. Biocompatibility of PMMA-containing photoresists. (A) Measurement of MTT 
metabolism by HeLa cells cultured on test substrates over 72 h. (B) Murine MSCs cultured 
on a film of PMMA/1002F with 0.25% (w/w) maghemite nanoparticles. The scale-bar is 100 
µm. 
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Figure 2.4. Workflow for micropallet isolation (A) Schematic of experimental setup for 
singe-cell isolation. Cells were loaded onto a micropallet array (each micropallet is 
100×100×50 µm L×W×H) mounted in a cassette. A laser pulse focused at the photoresist-
glass interface through a 0.7 N.A. objective was used to release individual micropallets from 
the array which were then attracted upward to the collection dish by the neodymium magnet. 
(B) A single HeLa cell possessing a fluorescent nucleus indicating expression of the histone-
H2B-GFP fusion protein growing for 24 h on a micropallet array fabricated from the 
magnetic PMMA/1002F composite. (C) After 48 h in culture, the single cell expanded into a 
colony. (D) The micropallet in “C” shown 96 h after release and collection demonstrating 
that the colony continued to expand with cells migrating from the micropallet onto the 
collection well surface. Panels B-D are overlaid brightfield and fluorescence images.  
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Chapter 3: Small Sample Sorting of Primary Adherent Cells by Automated Micropallet 
Imaging and Release 
 
3.1 Introduction 
Improvements in the sensitivity of molecular characterization tools have driven 
advances in our appreciation of the role that cellular heterogeneity plays in human disease 1,2. 
Little improvement has been seen, however, in techniques to prepare and process the small and 
often heterogeneous samples produced by in-vivo experiments and biopsies. While single-
purpose microfluidic platforms exist for processing small samples 3, many researchers and 
clinicians still rely on manual and onerous cell and colony picking approaches 1,4. A number 
of primary tissue sources pose significant challenges in yielding sufficiently large cell samples 
for conventional FACS sorting, often resulting in a need to pool tissue from a large number of 
organisms 5. Primary patient samples remain the ideal for biomedical research, yet the cost and 
complexity of acquiring them as well as an inability to source uniform samples over the course 
of an investigation limits their utility. Patient-derived tumor xenografts (PDX) in nude mice 
fill this gap by providing a consistent source of tumor tissue from an in-vivo context that, while 
less scalable than conventional tissue culture techniques, better maintains the phenotype and 
gene expression patterns of the originating tumor 6–9. Similar to patient samples, however, 
tumor biopsies and excisions from PDX mice are heterogeneous, having been infiltrated by 
murine immune, blood and vascular tissue 6, and are often limited in size. 
Fluorescence activated cell sorting (FACS) remains the gold standard for high 
throughput cell sorting. Current generation FACS instruments are capable of measuring more 
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than 20 parameters simultaneously 10 and achieve sort throughputs of greater than 50,000 
cells/s 11 but are typically operated on the order of 1,000’s of cells/s 12,13. The use of 
hydrodynamically focused flow to generate a stream of single cells for analysis and sorting has 
several key disadvantages. Single point observation precludes repeated measurements of 
individual cells to track dynamic properties. Adherent cells must be detached from a tissue 
culture surface, significantly altering cell morphology and cytoskeletal organization which 
may perturb intracellular signaling 14–16. Finally, the need to initialize sort gates combined with 
single point observation requires that a large number of cells be analyzed before a sort is 
possible, prohibitively decreasing the net effective sort yield for the very small samples that 
are typically obtained from primary tissue biopsies and small animal models 17. Several 
variants of laser capture microdissection (LCM) have been demonstrated for sorting small 
samples of live cells including gravity assisted microdissection and laser pressure catapult 
microdissection 18. Damage from the UV and IR lasers used in these approaches remains a 
concern 19. As a consequence, manual cell picking and limiting dilution remain the most 
commonly used techniques for sorting such exceedingly small primary cell samples. These 
approaches are laborious, time-consuming and, in the case of limiting dilution, can consume 
significant quantities of reagents.  
Micropallet arrays are an attractive and flexible platform for sorting and isolating cells 
from mixed samples 20. They consist of arrays of transparent and individually releasable 
pedestals fabricated by single-step photolithography on a glass substrate 21. Micropallets can 
be fabricated of various dimensions and array sizes optimized for sorting samples of varying 
size- from 102 to 106 cells 21,22. The micropallets serve as culture sites for cells and function as 
cell carriers upon release from the array. Individual micropallets are released by focusing a 
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low energy laser pulse at the photoresist-glass interface at high magnification and numerical 
aperture (20×, 0.7 N.A.) 23. Treating the glass substrate with a fluorinated silane renders the 
gaps between adjacent micropallets hydrophobic, trapping air when submerged in buffer or 
media 24. This trapped air, termed ‘virtual air walls’, prevents the migration of cells between 
adjacent micropallets. Additionally, the micropallets can be fabricated using a composite 
magnetic photoresist which enables the collection of micropallets against gravity by placing a 
permanent magnet above the array during laser release 25. Previous applications of micropallet 
array technology depended upon time-consuming manual inspection of the array to identify 
cells of interest followed by the manually triggered release of target micropallets, limiting the 
throughput and accessibility of the technology 26,27. 
Here we present an integrated platform for the automated imaging, analysis and release 
of micropallets from arrays. A software package was developed that supports rapid user 
initialization and automated multi-channel and multi-time-point imaging of uniform arrays of 
microstructures including, but not limited to, micropallet arrays, microraft arrays and 
microwell arrays. The package consists of two components: “Scan” and “Release” which 
incorporate the necessary functionality to allow for the identification of array elements bearing 
target cells and the release of identified target micropallets from the array. Scan throughput is 
a function of magnification and array geometry while release throughput is a function of the 
distance between targeted micropallets. The utility of the platform was demonstrated by sorting 
cells from very small samples (less than 104 cells) obtained from PDX models of a pancreatic 
ductal adenocarcinoma and a liver metastasis of a colorectal carcinoma. Cell selection was 
based upon fluorescent staining of human EpCAM (CD326) which is expressed in colorectal 
cancers 28 and many pancreatic tumors 29.  
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3.2 Materials and Methods 
3.2.1 Micropallet array fabrication 
Micropallet arrays were fabricated using PMMA/1002F photoresist containing 0.25% 
(w/w) maghemite nanoparticles which had been prepared as previously described 25. Briefly; 
a glass slide was coated with a 75 µm thick film of photoresist by spin coating in 2 steps: 10 s 
at 500 rpm followed by 30 s at 1,000 rpm. The photoresist film was baked to remove solvent 
at 95 °C for 1 h after which it was exposed to long-wave UV (360 nm longpass) for 6 min in 2 
min intervals with 1 min between exposures to prevent sample heating. After exposure the 
photoresist was cross-linked by heating to 95 °C for 10 min and the unexposed photoresist was 
dissolved by developing in 1-methoxy-2-propyl acetate for 5-7 min, rinsed with 2-propanol 
and dried under a nitrogen stream. The resulting array was then cut to size in order to fit into a 
sample cassette which had been 3D printed out of acrylonitrile butadiene styrene (ABS) using 
a conventional extrusion-based printer (BFB-3000, Bits from Bytes Ltd, now 3D Systems Inc. 
Rock Hill, SC). The array was then oxidized in an air plasma (Harrick Plasma, Ithaca, NY) 
and reacted with (heptadecafluoro-1,1,2,2-tetrahydrodecyl) trimethoxysilane (Gelest Inc. 
Morrisville, PA) in a low-pressure chamber for 24 h to generate the virtual air walls as 
previously characterized 24. After silanization the arrays were rinsed with 75% ethanol, dried 
under a stream of nitrogen and baked for 10 min on a 120 °C hot plate. The arrays were then 
glued into 3D printed cassettes with polydimethylsiloxane (PDMS) which was then cured for 
30 min in a 70 °C oven. The glued cassettes were sterilized with 75% ethanol prior to use. 
3.2.2 Automation of array scanning 
An automated array scanning (process flow shown in Figure 3.1A) utility was 
implemented in the open-source, cross-platform Python programming language (Python 
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Software Foundation, python.org) with a user interface (Figure 3.1B) built using the Qt 
framework (Qt Project, qt-project.org). Microscope, stage and camera control libraries were 
provided by the open source microscopy control package Micro-Manager 30 through its Python 
interface. The microscope platform consisted of an inverted frame (Olympus IX81, Olympus 
Corporation of the Americas, Center Valley, PA), a motorized XY stage (MS-2000, Applied 
Scientific Instrumentation, Eugene, OR), a metal arc lamp excitation source (Lumen 200, Prior 
Scientific, Rockland, MA), high speed shutter (Lambda 10-2, Sutter Instrument Company, 
Novato, CA) and cooled interline CCD camera (CoolSnap HQ2,  Photometrics, Tucson, AZ). 
For live-cell imaging, the microscope was enclosed in a custom fabricated black Delrin 
housing with temperature, humidity (AirTherm ATX-H, World Precision Instruments, 
Sarasota, FL) and CO2 (ProCO2, BioSpherix, Lacona, NY) regulation. 
Array scan automation was implemented in three steps: array geometry initialization, 
focus plane initialization, and array scanning. Array geometry initialization is a user-assisted 
process. The user inputs the general geometry of the array (the height and width of each 
element, the gap between each element and the number of rows and columns in the array) and 
positions the field-of-view at one corner of the array. A linear slider adjusts an intensity 
threshold which is applied to the image and the results overlaid on the video display, options 
are provided to limit the minimum and maximum object size as well as to close holes by 
mathematical morphology. The user identifies which corner of the array (top left, top right, 
bottom left or bottom right) is currently in the field of view. Based on the corner selected, three 
thresholded array elements are identified: the element closest in the image to the corner 
selected and the two elements closest to the adjacent corners of the image relative to the corner 
selected. The position of the corner element is stored and the vectors from the centroid of the 
82 
 
corner element to the adjacent corners of the field of view are measured and used to estimate 
the position of the remaining three corners of the array. The user then selects one of two 
methods to measure the positions of the remaining corners: navigating to and measuring the 
position of the two corners adjacent to the first corner, or navigating to and measuring the 
position of the corner opposite of the first corner to be initialized.  
The initialization process (adjust threshold, close holes and identify active corner) is 
repeated at each corner to confirm their positions after quickly seeking to their approximate 
position based on the estimate made during the initialization of the first corner. The 
initialization of the focus plane can be carried out before, after or simultaneously with the array 
geometry initialization. To initialize the focus plane, the user selects at least 4 positions in the 
array (recommended to be near the array corners) to manually focus on a cell present on the 
micropallet surface. After initialization, singular value decomposition (SVD) is used to 
calculate the normal vector of the plane of best fit that passes through the user-initialized point-
cloud. The eigenvector with the smallest corresponding eigenvalue from the SVD of the point-
cloud is selected as the normal vector used to calculate the equation of the plane of best fit 
which passes through the centroid of the point-cloud.  
In the final step, discrete fields of view are identified beginning with the upper left 
corner of the array and providing full coverage of the array without dividing any elements 
between adjacent fields of view to prevent errors from inaccurate stitching. Each field of view 
is imaged sequentially based on the selected exposure, gain and filter positions and segmented 
into images of each individual element of the array present in the image based on their 
calculated positions from the array geometry initialization. A nested directory structure is 
generated for each time-point (if multiple are selected) containing separate folders for each 
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channel to which are saved individual 16-bit grayscale tif images of each micropallet with its 
absolute row and column position within the array indicated in the image filename. The nested 
directory structure allows the use of a variety of common image analysis tools such as 
CellProfiler 31, ImageJ 32 and custom scripts implemented in MATLAB (The Mathworks Inc. 
Natick, MA). 
3.2.3 Image analysis 
 Nuclear segmentation of PDX cells stained with Hoechst 33342 (Sigma Aldrich, St. 
Louis MO) was implemented using a CellProfiler pipeline. The image fluorescence 
background was estimated using a 40 pixel diameter grayscale opening operation and 
subtracted from the original image. A 3 × 3 pixel wide median smoothing filter was applied to 
the background-subtracted image to reduce over-segmentation of nuclei. A global two-class 
Otsu method was selected for automatic thresholding with an empirically tuned threshold 
correction factor and minimum threshold to adjust for variations in Hoechst staining and 
background fluorescence between arrays. CellProfiler’s shape-based watershed method was 
used to declump nuclei. Finally, an attempt was made to reduce false positives from debris 
remaining in the sample after enrichment by filtering the segmented objects based on their size 
(10 – 40 pixel allowable diameter), maximum eccentricity (0.9) and an empirical threshold on 
the integrated fluorescence of the candidate nucleus (adjusted based on variations in staining 
intensity between experiments). An image mask was then generated from the filtered object 
list and saved to disk to be used by a custom MATLAB script to process the resulting data. 
The CellProfiler pipeline developed is provided in supplementary files. A MATLAB script 
was utilized to identify images containing a single cell as segmented by CellProfiler. The 
segmented masks were then dilated by 10 pixels and phycoerythrin (PE) fluorescence within 
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the dilated neighborhood was integrated after background subtracting by grayscale opening (a 
40 pixel diameter disk structuring element was used). The distribution of integrated PE 
fluorescence intensities was then displayed to the user and a threshold fluorescence was 
empirically selected based on the observed distribution and inspection of representative images 
of cells at different intensity values in the distribution. The row and column coordinates of 
cells that met both criteria (identification of a single nucleus by CellProfiler and greater than 
threshold fluorescence in the PE channel) were then exported into a plain text file to be read 
by the micropallet release utility. 
3.2.4 Automation of micropallet release 
Micropallet release was automated using a similar approach to scanning. First, a user 
initialized the array positions by locating two opposing or three adjacent corners of the array 
after inputting the array geometry into the release interface. A focus plane was also initialized 
using a minimum of 4 points to calculate a plane of best fit by SVD. This focus plane was 
initialized by the user at the base of the micropallets rather than their top surface as the laser 
must be focused at the glass-photoresist interface to effect micropallet release. Once the array 
positions and focal plane were initialized the user could either move to manually specified 
micropallets or load a list of target micropallets by their row and column coordinates. If a list 
of target micropallets was loaded, the release program successively moved to the position of 
each target micropallet, focus the 20× objective and trigger a 532 nm Nd:YAG pulse laser 
(Polaris, New Wave Research, Fremont, CA) to fire. The appropriate laser pulse energy to 
achieve reliable micropallet release varied from batch to batch and ranged from 5 to 8 µJ. An 
Arduino Uno microcontroller board (SparkFun Electronics, Boulder, CO) controlled with 
serial commands over USB by the Python release program was used to trigger the pulsed laser 
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by delivering a 1 ms long 5 V pulse to the laser trigger input port. Fully automated release of 
a large number of micropallets was demonstrated by reproducing several images on 
micropallet arrays. This was achieved by converting the images into lists of target micropallets 
by down-sampling the image to the same number of rows and pixels as were present in the 
micropallet array, applying an empirical threshold to the resulting image and finding the row 
and column indices of every pixel with a value of 0 using a MATLAB script. 
3.2.5 Micropallet array fabrication and collagen coating 
 Micropallet arrays were fabricated from a composite of poly(methylmethacrylate-co-
methacrylic acid) (PMMA/MMA) and 1002F photoresist containing 0.25% (w/w) maghemite 
nanoparticles which had been prepared as previously described 25. Arrays of 10,000 
micropallets (100 × 100, rows × columns) measuring 100 × 100 × 35 µm (length × width × 
height) each were fabricated using spin coating, baking and UV exposure parameters that were 
previously identified. After fabrication, virtual air walls were generated by vapor coating the 
arrays with (heptadecafluoro-1,1,2,2-tetrahydrodecyl)-1-trichlorosilane in a low-pressure 
reactor for 16 h 24. The silanized micropallet arrays were then glued into custom sample holders 
fabricated by 3D printing polylactic acid (PLA) on a fused deposition modeling printer (see 
above) with a small amount of polydimethylsiloxane (PDMS) which was cured for 30 min at 
75 °C. After curing the glue, the array and cassette were sterilized by spraying with 75% 
ethanol and air drying.  
After sterilization, the arrays were coated with collagen to promote PDX cell adhesion 
by a previously described physical deposition method 20. Briefly, the arrays were incubated in 
0.01% poly-L-lysine (Sigma-Aldrich, St. Louis, MO) at 25 °C for 16 h. Excess poly-L-lysine 
was removed by rinsing 3× with de-ionized water and replaced with a solution of 400 ng/mL 
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of type I collagen from rat tail (Becton Dickinson, Franklin Lakes, NJ) and incubated at 25 °C 
for 1 min. The collagen solution was then aspirated from the array and the remaining droplets 
of the solution trapped on the hydrophilic micropallet surfaces were allowed to air-dry for 15 
min. After drying, the collagen film was rendered insoluble by immersing in phosphate 
buffered saline (PBS; 137 mM NaCl, 10 mM Na2HPO4, 27 mM KCl, 1.75 mM KH2PO4, pH 
7.4) and used within 24 h.  
3.2.6 Patient-Derived Xenografts 
Fresh tumor samples from pancreatic ductal adenocarcinoma and colorectal carcinoma 
patients were obtained under protocols approved by the University of North Carolina 
Institutional Review Board. The tumors were subcutaneously implanted into the flanks of 
immunocompromised mice and subsequently expanded and passaged, using protocols 
approved by the Institutional Animal Care and Use Committee. At the time of passage, a 
section of the tumor was cut into <3 mm pieces and rinsed with PBS containing penicillin and 
streptomycin (P/S). The tissue was minced with using the gentleMACS™ Dissociator 
(Miltenyi Biotec, Bergisch Gladbach, Germany) and incubated for 30 min in a 1 mg/ml 
collagenase/dispase (Roche 11097113001) solution. After incubation, mincing was repeated, 
the dissociation media was removed and the tissue was seeded as described below. 
3.2.7 Culture and staining of PDX cells 
 PDX samples were received in suspension after enzymatic digestion and dissociation. 
After transport on ice, the samples were pelleted by centrifugation at 800 RCF for 2.5 min and 
resuspended in 5 mL of Dulbecco’s Modified Eagle Medium (DMEM, Gibco® Life 
Technologies, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, Thermo 
Scientific, Waltham, MA), 500 ng/mL gentamicin sulfate  and 250 ng/mL amphotericin B (Life 
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Technologies,  Carlsbad, CA). Due to the large amounts of tissue debris and dead cells 
generated from the PDX extraction and disaggregation, the samples were enriched by plating 
the suspension onto a 25 cm2 tissue culture treated flask for 48 h to permit live cells to adhere. 
After 48 h, the cells were rinsed 3× with PBS to remove dead cells and debris and 
enzymatically released from the tissue culture surface (10 min at 37 °C in 0.05% Trypsin). The 
cells were then pelleted and re-suspended in 3 mL of culture medium of which 1 mL was plated 
onto the prepared collagen-coated micropallet array for staining, imaging and sorting.  
After plating the suspension of PDX cells onto the collagen-coated micropallet array, 
the arrays were incubated for 48 h to allow the cells to attach. After 48 h, the arrays were rinsed 
3× with PBS to remove remaining debris and dead cells and immersed in 37 °C extracellular 
buffer (ECB; 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 
7.4). Hoechst 33342 (500 ng/mL) and PE-conjugated anti-CD326 (750 ng/mL, clone VU-1D9 
mouse anti-human, Life Technologies, Carlsbad, CA) were added to the array and incubated 
at 37 °C for 15 min. The array was then rinsed 3× with fresh ECB and covered with an ethanol 
sterilized glass slide held 1 mm above the array surface by the sample cassette in direct contact 
with the ECB to maintain fluid contact during imaging and sorting. 
3.2.8 Automated identification and sorting of EpCAM+ PDX cells 
After initializing the array geometry and focus plane as described above, the array was 
scanned using DAPI and Texas Red filter cubes (Chroma Technology, Bellows Falls, VT). 
After scanning, the Hoechst fluorescence images were segmented by a CellProfiler pipeline 
and processed by a custom MATLAB script which then integrated fluorescence from the PE 
channel. An empirical threshold was determined based on the distribution of fluorescence 
intensities measured and direct inspection of representative raw images, and the coordinates 
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(row and column number) of micropallets bearing a single cell with greater than threshold PE 
fluorescence were exported in a plain text file to be read by the release script. After initializing 
the release application, the target micropallet list was loaded and release of the first micropallet 
in the list was triggered manually to verify that laser focus and pulse energy were sufficient to 
effect release. The automated release program was then started and the video feed was 
observed throughout the process to confirm the successful release of each targeted micropallet. 
Released micropallets were collected using a magnet (K&J Magnetics, Pipersville, PA) placed 
above a collection plate overlaying the array. After the completion of the automated release, 
the collected micropallets were inspected to verify the retention of the targeted cell during 
micropallet release as well as its PE fluorescence. 
3.3 Results 
3.3.1 Automated array scanning 
Micropallet array scanning was set up in 2 key steps: user initialization of the array 
geometry and user initialization of focus points in the array (Figure 3.1). Based on the geometry 
of the array (size and number of micropallets) and the user-initialized locations the array’s 
corners, the scan system interpolated the position of every micropallet in the array. Autofocus 
was simplified by the planar nature of the top surface of the micropallet array- a plane of best 
fit was calculated by singular value decomposition from a set of user-initialized focus points 
distributed over the array. The plane-of-best fit reduced autofocus within the array to a look-
up table problem, dramatically improving throughput over image-based autofocus solutions 
with typical errors (as compared to manual focus) smaller than the depth of field of a 20× 
objective (2.74 ± 1.37 µm, n=3). Scans could be configured over multiple time-points with up 
to 5 fluorescence channels per field of view. Each field of view was automatically segmented 
89 
 
into images of the individual micropallets based on their interpolated positions and known 
geometry. The throughput of array scanning depended on 4 variables: field of view, dwell time, 
array geometry (element dimensions) and the travel time between adjacent fields of view. The 
travel time between adjacent fields of view was a function of the distance between adjacent 
fields of view and therefore magnification. At 10× magnification the travel time was 750 ms. 
The travel time could be reduced by increasing the acceleration of the stage, but this resulted 
in decreased positional accuracy and repeatability. For an array with 100 µm square elements 
and a 30 µm gap between adjacent elements, a single field of view at 10× magnification 
contained 35 elements. For a 500 ms dwell time at each field of view, the effective throughput 
was 28 elements/s and a 10,000 element array could be scanned in under 6 min per channel. 
Since the density of cell seeding onto arrays is governed by Poisson statistics, the maximization 
of single-cell occupancy of an array occurs at a ratio of 1 seeded cell per array element and 
corresponds to an average of 36.8% of micropallets possessing a single cell. This yielded an 
expected maximum theoretical scanning throughput of 10.3 cells/s at 10× magnification with 
a 500-ms dwell time. This throughput can be increased dramatically by reducing array element 
size since throughput is dependent on the cross-sectional area of each array element. 
3.3.2 Automated micropallet release 
The general workflow for automated micropallet release was very similar to that of 
micropallet array scanning with one key difference. Rather than initializing the focus plane at 
the top surface of the micropallets, the photoresist-glass interface was used as the focal plane 
since the laser pulse must be delivered at this interface to effect micropallet release. After 
initialization of the array geometry and focus plane, there were two modes of operation for 
release: manual and automated targeting. In manual operation the user could seek to specific 
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row and column coordinates within the array and initiate release directly. In automated 
operation, the user loaded a plain text file containing a list of row and column numbers with 
commas separating the row and column and line breaks separating each targeted micropallet. 
The release utility then stepped through each position, focused the objective and fired the laser 
once to effect micropallet release (Figure 3.2A).  Released micropallets were then attracted 
upwards to a collection plate by a ring-shaped permanent magnet placed above the array. To 
demonstrate the automated identification and release of a large number of targeted 
micropallets, a pattern was generated by releasing specific elements from micropallet arrays 
by processing a black and white image in MATLAB. The image was re-sized to contain the 
same number of pixels as micropallets were present in the array (200 rows × 200 columns, 
40,000 elements or pixels total) and a list of the coordinates of pixels with value 0 was 
generated and used as the release input file (Figure 3.2B). The target list was then loaded into 
the release utility and the automated release process was initiated. A peak release throughput 
of 3 micropallets/s was achieved which was limited primarily by the time required for stage 
motion which was a function of the distance between subsequent micropallets targeted for 
release. Over 10,000 micropallets were released in each of the arrays to reproduce the graphical 
images on the micropallet array (Figure 3.2C). In all three examples shown, 100% of targeted 
micropallets were confirmed to have successfully released by visual inspection. 
3.3.3 Automated identification of PDX cells on micropallet arrays 
 PDX cells were seeded onto micropallet arrays in suspension and allowed to adhere for 
48 h. The arrays were then stained with Hoechst 33342 and PE-conjugated anti-EpCAM and 
imaged using the automated micropallet array scanning utility. Images from the Hoechst 
channel were segmented using CellProfiler and PE fluorescence was measured for micropallets 
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that were identified as having only one cell. An empirical threshold for PE fluorescence was 
determined from the distribution of PE fluorescence intensity and by manually inspecting 
representative images to classify EpCAM+ cells. All micropallets identified as having a single 
EpCAM+ cell were released from their respective arrays using the automated release utility.  
In total, three PDX samples were analyzed and sorted using the automated system. Two 
PDX samples were derived from the same patient tumor: a liver metastasis of a colorectal 
carcinoma (CRC1 and CRC2) but cultured in different mice. The third PDX sample originated 
from a pancreatic ductal adenocarcinoma (PDAC) and yielded 8× as many total cells per 
volume of sample as either the CRC1 or CRC2 samples. A total of 7,584 cells were identified 
on the array seeded from PDAC whereas the CRC1 and CRC2 arrays possessed 875 and 1087 
cells, respectively. In total, 1,750 (PDAC), 403 (CRC1) and 764 (CRC2) micropallets were 
identified as containing a single cell. 
To evaluate the accuracy of the segmentation pipeline for each of the three samples, 
100 randomly selected micropallets were manually inspected from the population to determine 
whether the image analysis pipeline correctly identified a single cell. In addition, 100 randomly 
selected micropallets identified as containing no cells were also manually inspected to confirm 
the absence of cells. From the micropallets that were identified as bearing a single cell, the 
false positive rate (FPR) was determined to be 0%, 9% and 8% for PDAC, CRC1 and CRC2, 
respectively. For both CRC samples, looser criteria to filter potential single cells were used to 
maximize the number of EpCAM+ cells identified due to the significantly lower total number 
of cells available in the sample. As a consequence, however, this resulted in a higher FPR due 
to the misclassification of fluorescent debris and light scatter from micropallet edges. 6% of 
the micropallets identified from PDAC as having a single cell were found to be 
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undersegmented and contained 2 nuclei, although it was not clear what fraction of these were 
true doublets as opposed to single multinucleated cells. For the micropallets identified as 
containing no cells, only a single micropallet from the PDAC image set was identified as being 
a false negative, resulting in a false negative rate (FNR) of 1% for PDAC and 0% for both 
CRC1 and CRC2, and an aggregate FNR of 0.33%.  
After identifying micropallets containing single cells, the PE fluorescence of each cell 
was measured by a MATLAB script which integrated pixel values in the PE channel image 
within a 10-pixel radius of the segmented images produced by CellProfiler. The distribution of 
the number of cells per micropallet is shown in Figure 3.3A-C. Of the micropallets identified 
as containing a single cell, 257 (14.7%, PDAC), 7 (1.7%, CRC1) and 16 (2.1%, CRC2) 
micropallets were determined to contain a single EpCAM+ cell based on the empirically 
determined thresholds identified from the distributions shown in Figure 3.3D-F. Differences 
in the percentage of EpCAM+ cells are believed to be due to variations in the degree of 
infiltration of host stromal tissue into the xenograft tumor while the total number of live cells 
isolated likely depended on the relative size of each tumor as well as the degree of necrosis 
and fibrosis present. 
3.3.4 Sorting EpCAM+ PDX cells from host tissue contamination 
 All micropallets with a single EpCAM+ cell on the arrays seeded with the CRC1, CRC2 
and PDAC PDX samples were released and collected using the automated micropallet release 
utility. The largest scale release, 257 micropallets from the array seeded by the PDAC PDX, 
sample completed in 3.75 min and achieved a mean throughput of 1.14 cells/s. The release of 
7 cells from the CRC1 array and 16 cells from CRC2 array achieved much lower effective 
throughputs due to the greater distance between adjacent targeted micropallets and required 25 
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s and 42 s to complete, respectively. The automated release process was monitored visually for 
all three arrays and 99.6% of all micropallets that were targeted for release were successfully 
released. The single micropallet that failed to release from the CRC2 array was observed to be 
trapped by a thick layer of collagen gel due to a defect produced during the coating process. 
The purity and yield of each sort was confirmed by directly inspecting collected micropallets. 
For the micropallets released from the PDAC array, a subset of 17 collected micropallets were 
re-imaged (Figure 3.4). Two micropallets were observed to each have two nuclei present (and 
presumably two cells). One micropallet was observed that was collected without a cell 
attached. All cells on these micropallets were EpCAM+ resulting in a purity of 100%. The 
yield for correctly identified and collected pallets with a single PDAC EpCAM+ cell was 82% 
(14 of 17). For CRC1 and CRC2, all 7 and 15 successfully released micropallets were 
confirmed to have been collected. All 7 micropallets collected from the CRC1 sample were 
observed to carry a single, EpCAM+ cell, resulting in 100% yield and purity. For CRC2, all 
collected cells were EpCAM+ indicating 100% purity. However, a single micropallet 
possessed two nuclei resulting in a net yield of 93% i.e.14 of 15 micropallets correctly 
possessed a single EpCAM+ cell following collection.  
3.4 Discussion 
In this study, we describe the integration of the micropallet-array technology with an 
automated microscopy platform to enable flexible analysis and sorting of very small primary 
tissue samples. A software package was developed with a graphical interface that permits rapid 
and easy array configuration and imaging. At 10× magnification, an overhead of 750 ms was 
necessary for stage motion, image acquisition and writing the acquired images to disk per field-
of-view. A single channel scan over an array of 10,000 micropallets (100 × 100 µm) with a 
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500 ms dwell time for each field-of-view was completed in under 6 min with less than 2 min 
typically required for the initial set-up of the scan. Since the seeding of cells onto micropallet 
arrays is described by Poisson statistics, an average of 36.79% of micropallets in an array are 
expected to contain a single cell and therefore an ideally seeded array of similar geometry 
would achieve a mean imaging throughput of 10.3 cells/s. While this aggregate throughput is 
lower than that possible by imaging cells seeded at higher densities on a planar or arrayed 
surface, micropallet arrays enable these cells to be sorted based on both image measurements 
and temporal criteria, dramatically expanding the selection criteria that can be used (13). 
Furthermore, the retention of adherent cells seeded onto the micropallet array surface enables 
extremely small samples to be sorted with higher yield than existing automated solutions 17 
and significantly faster than manual approaches such as limiting dilution or cell picking.  
Increased use of cytogenetics in clinical oncology and cancer research 33–35 has 
highlighted a need for advances in cell selection, enrichment and purification techniques 
compatible with the often heterogeneous and small samples that can readily be obtained from 
patient biopsies and animal models. To demonstrate the ability of micropallet array technology 
to characterize and sort small working samples, a proof-of-concept was implemented using 
PDX models of pancreatic and colorectal cancers. Samples acquired from the tumors used 
exhibit differing levels of purity due to the variable infiltration of tumor cells with that of the 
murine host tissue. The high cost of maintaining PDX mouse colonies, the relatively short 
usable lifespan of a xenograft (recommended <10 passages6) and the need to minimize the 
number of animals sacrificed lend significant value to the ability to increase the number of 
experiments that can be performed from each PDX. The proof-of-concept sort was performed 
with initial sample sizes ranging from 875 to 7,584 cells. Three samples were ultimately sorted 
95 
 
with a mean yield of 90% and purity of 100%. This performance greatly exceeded previously 
published attempts with MACS and FACS to sort similarly sized samples in both effective 
yield and purity (for 103 cells, FACS: 0% yield, MACS: 14% purity, 30% yield)17. The 
integration of the micropallet sorting automation with automated imaging and image analysis 
also enables applications requiring a time-series or morphological data from adherent cells, 
selection criteria for which no alternatives exist in either MACS or FACS. Previous studies 
with micropallet array-based sorting have also demonstrated very high rates of post-sort 
viability 21,36,37. As a single laser-pulse is required per released micropallet, the potential exists 
for the development of instruments with significantly higher sorting throughput than LCM-
based live-cell sorting technologies. 
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3.5 Figures 
 
 
Figure 3.1. Overview of micropallet array scan automation (A) The process flow by which the 
implemented utility scans over micropallet arrays. The two initial steps (Load Array Geometry 
and Locate Focus Points) were user-assisted, following which the initialized array could be 
scanned in a fully automated fashion. (B) A screenshot of the Scan utility user interface 
showing image acquisition settings as well as the panel for configuring the micropallet array 
geometry.  
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Figure 3.2. Overview of micropallet release automation (A) Schematic rendering of 
micropallet array experimental setup showing an array mounted in a 3D-printed cassette with 
a glass slide and permanent magnet placed on the cassette for micropallet collection after 
release. The inset shows an expanded view of the micropallet array. The white asterisk marks 
a released and collected micropallet. (B) A graphical representation of the process by which 
target micropallets are located through a list generated from a “mask” of the array pixel-by-
pixel. The release utility sequentially steps through the target list and fires a laser pulse at each 
micropallet. (C) Examples of micropallet arrays (50 µm cube micropallets, 200 × 200 
micropallets per array) from which large numbers of micropallets were released in an 
automated fashion (>10,000). The target lists were generated from mask images with the same 
number of pixels as micropallets present in the array. 
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Figure 3.3. Image analysis of PDX samples (A-C) Heat-maps showing the number of PDX 
cells identified on each micropallet in the array (each pixel corresponds to a single micropallet) 
by CellProfiler. (D-F) Histograms of the log-transformed integrated PE fluorescence (marking 
EpCAM) for each micropallet identified as containing a single-cell. 
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Figure 3.4. PDX cells sorted using micropallets (A-C) Example images of individual EpCAM+ 
cells successfully identified on micropallets prior to release. (D-E) Example images of 
micropallets with EpCAM+ cells but greater with than one nuclei which were not successfully 
declumped by the CellProfiler pipeline. (F) Released micropallets successfully collected from 
the PDAC sample. Asterisks mark identified cell nuclei, showing 1 micropallet with two nuclei 
and 1 micropallet without a nuclei. The visible red spot at the center of each pallet is the laser 
impact site which strongly scatters light. 
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Chapter 4 Dynamics and evolution of b-catenin-dependent Wnt signaling revealed 
through massively parallel clonogenic screening 
  
4.1 Introduction 
Wnt/β-catenin signaling is an evolutionarily conserved signaling pathway that is 
involved in development, adult tissue homeostasis, tissue regeneration, and disease.  In the 
absence of Wnt ligand signaling, β-catenin levels are kept low through ubiquitination and 
proteosome-dependent degradation. Specifically, cytosolic β-catenin is captured by a 
complex of proteins comprising GSK3β, CK1a, APC and AXIN, which promote its 
phosphorylation and subsequent ubiquitination by the β-TrCP ubiquitin ligase. Binding of the 
Wnt ligand to the frizzled receptor inhibits GSK3b-dependent phosphorylation of b-catenin, 
leading to increased b-catenin levels and stability. β-catenin is then translocated to the 
nucleus and acts as a co-activator for TCF/LEF family transcription factors. Wnt signaling 
interacts with a large number of signaling pathways in normal and pathological contexts and 
large-scale screening efforts continue to identify many novel regulators and potential 
therapeutic targets.1–4 The importance of single-cell measurements in the study of tumor 
systems and signaling pathways has been highlighted by the observation of significant 
heterogeneity in Wnt signaling at the single-cell level in primary tumor-derived spheroid 
cultures5 as well as by mounting evidence for the role of genomic and phenotypic 
heterogeneity in the evolution and adaptation of tumors.6–9 
Transcriptional reporters based on the production of chemiluminescence and 
fluorescence signals have been used successfully in the study of a wide variety of signaling 
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pathways.10–13 Transcriptional reporters of Wnt/β-catenin signaling have been employed with 
great success leading to the discovery of several novel regulators of Wnt signaling.1–3,11 Since 
Wnt/β-catenin signaling culminates in the co-activation of TCF/LEF family members, 
transcriptional reporters of Wnt/β-catenin signaling typically contain multiple TCF/LEF 
binding sites upstream of a reporter gene. While transcriptional reporters measure Wnt 
pathway activation by virtue of the induced activity of downstream transcription factors, 
direct measurements of signaling activation are also possible by tracking the localization of 
β-catenin. Immunohistochemical methods permit observation of nuclear accumulation of β-
catenin as a readout for Wnt pathway activation14, however the dynamic range and the 
strength of the signal can vary widely as Wnt signaling is highly sensitive to changes in 
nuclear β-catenin levels rather than the absolute amount present.15 Additionally, staining can 
only be performed in fixed cells and significant amounts of β-catenin will be present in 
adherens junctions at the cell membrane making measurement of nuclear concentrations 
challenging. Fusions of β-catenin and fluorescent proteins enable high-contrast, real-time 
tracking of signaling in live cells16; however, this strategy suffers from many of the same 
disadvantages of immunohistochemistry with respect to dynamic range and signal strength. 
In addition, there remains the risk that the fusion protein significantly alters the function and 
dynamics of protein degradation and translocation due to potential steric hindrance from the 
addition of the bulky fluorescent protein component.  For these reasons, transcriptional 
reporters of Wnt/β-catenin signaling remains the most widely used method to measure 
pathway activation in living cells. 
Modern techniques for the study of intracellular signaling depend on the availability 
of robust and rapid measures of intracellular signaling activity. The quantitative biomolecular 
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and biophysical characterization of intracellular signaling is highly dependent on the 
dynamic range and intensity of the reporter signal. While luminescent reporters (through the 
use of firefly luciferase as the reporter gene17) remain the most sensitive readout for reporter 
activation, fluorescent protein-based reporters permit measurement of reporter activation in 
single, live cells.18  In an attempt to reduce cell-to-cell variability to permit more sensitive 
measurements pooled over multiple cells, monoclonal cell lines are often employed for 
fluorescent reporters.19–23 Noise from polyclonal variability can also be reduced by averaging 
measurements over a larger number of cells but this leads to increased reagent consumption, 
reduced throughput and limited dynamic range. These dynamics and variability of 
fluorescent transcriptional reporters for β-catenin have not been well characterized in the 
literature, particularly in the context of the evolution of reporter performance in monoclonal 
cell lines. 
This study presents a detailed characterization of a β-catenin activated reporter 
driving expression of a nuclear localization signal tagged red fluorescent protein (BAR-
mCherry) in A375, a cell line derived from human melanoma24 that does not exhibit 
abnormal nuclear accumulation of β-catenin.25 The dynamics of BAR-mCherry activation 
and relaxation were measured in 6 monoclonal cell lines expanded from single isolated 
A375-BAR-mCherry cells. A parallel clonogenic assay was implemented using 
microfabricated cell arrays to characterize the emergence of heterogeneous reporter 
activation over time-scales significantly shorter than that required to expand single cells into 
monoclonal cell lines. A detailed study of the dynamics of transcriptional reporter activation 
in monoclonal populations would be of significant value in the design and optimization of 
assays utilizing similar reporter systems. Additionally, parallel clonogenic screening of 
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reporter cell line colonies may shed light on the mechanisms by which reporter cell lines 
evolve and enable the generation of more stable and uniform reporter libraries. 
4.2 Materials and Methods 
4.2.1 Plasmids, Cell Culture and Transfection 
A375 human melanoma cells were sourced from the American Type Culture 
Collection (ATCC). pSL9-BAR-NLS-mCherry was made by mutating pSL9-BAR-
Luciferase using site directed mutagenesis to allow for subcloning of NLS-mCherry. The 
NLS-mCherry construct was a gift of Jon Lane.  A375 cells were infected with pSL9-BAR-
NLS-mCherry as described previously and will be referred to as A375-BAR-mCherry for 
brevity.13 Cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Life 
Technologies, Carlsbad, CA) with 10% fetal bovine serum (FBS, Thermo Scientific, 
Waltham, MA), 500 ng / mL gentamicin sulfate and 250 ng / mL amphotericin B (Life 
Technologies, Carlsbad, CA).  
4.2.2 Microraft Array Fabrication 
 The 6 monoclonal A375-BAR-mCherry cells were isolated using a microraft array 
platform. Microraft arrays were fabricated as previously described.1 Briefly; microraft 
master molds were prepared by single layer photolithography using 1002F photoresist and a 
chrome mask with a pattern of 110×110 200 µm square apertures with a 30 µm gap.2 After 
fabrication of the master, the microraft array substrate was prepared by casting 
polydimethylsiloxane (PDMS; Sylgard 184, Dow Corning Corp., Midland MI) onto the mold 
and curing at 95 ºC for 1 hour. The PDMS well array was then demolded from the master and 
filled by overlaying a solution of 30% polystyrene in γ-butyrolactone with 3% iron oxide 
nanoparticles by weight and applying vacuum. The filled microwell array was then lowered 
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into a bath of excess magnetic polystyrene solution and slowly withdrawn at a rate of 25 
mm/h to achieve discontinuous dewetting. The dip-coated microwell array was then baked 
overnight at 95 ºC to remove solvent from the polystyrene and harden the microrafts. The 
fabricated microraft arrays were mounted to cassettes, oxidized in an air plasma (Harrick 
Plasma, Ithaca, NY) for 5 min and sterilized with 75% ethanol and air-dried immediately 
prior to use.  
4.2.3 Micropallet Array Fabrication 
 Micropallet arrays were utilized for the parallel clonogenic screening due to the 
ability of stable virtual air walls to prevent migration of the cell type employed for extended 
periods of culture. Micropallet arrays were fabricated as previously described using a 
composite photoresist of poly(methyl methacrylate-co-methacrylic acid) and 1002F termed 
PMMA/1002F.3,4 Briefly, a 35 µm thick layer of photoresist was generated on glass slides 
by spin coating in two steps: 500 rpm for 10 s followed by 2500 rpm for 30 s. The film was 
then dried by soft baking at 95 ºC for 1 h. The film was then exposed using a 360 nm long-
pass filter for 3 exposures lasting 1 min each with a 1 min gap between each exposure to 
prevent excessive heating of the photoresist. After exposure the film was cross-linked by 
baking at 95 ºC for 10 min and developed in 2-methoxypropylacetate for 4 min. After 
developing the micropallet arrays were oxidized in an air plasma for 5 min prior to 
silanization. To establish stable virtual air walls, 100 µL of (Heptadecafluoro-1,1,2,2-
tetrahydrodecyl)trichlorosilane (Gelest Inc, Morrisville PA) was added to a dish adjacent to 
micropallet arrays placed in a dry-seal vacuum dessicator (Wheaton, Millville NJ) and a 
vacuum was applied using an oil-free pump for 2 min. The dessicator was then sealed and 
incubated for 16 h. After 16 h, vacuum was again applied for 30 minutes to remove excess 
110 
 
silane and the treated micropallet arrays were removed. The micropallet arrays were then 
immediately mounted into cassettes and sterilized with 75% ethanol prior to use. 
4.2.4 Conditioned Media and Reagents 
Control and Wnt-3a transfected L-cells were obtained from the ATCC and 
conditioned media was prepared according to ATCC protocol. Murine recombinant Wnt-3a 
was purchased from Sigma-Aldrich and reconstituted at 1 mg/mL in deionized (DI) water 
with 0.1% bovine serum albumin and stored in aliquots at -80 °C. Aliquots were thawed and 
diluted further with phosphate buffered saline (PBS; 137 mM NaCl, 10 mM Na2HPO4, 27 
mM KCl, 1.75 mM KH2PO4, pH 7.4) and used immediately. The GSK3β inhibitor CT 99021 
(CHIR 99021, Axon Medicinal Chemistry, Vienna, VA) was stored as a 10 mM solution in 
DMSO at -20 °C.  
4.2.5 Cell Cloning Using Arrays of Releasable Microstructures 
Single A375-NLS-mCherry cells were isolated and expanded using arrays of 
releasable microstructures as a cloning platform.26 The arrays were sterilized by rinsing with 
70% ethanol and air-drying prior to use. A suspension of 4,000 A375-NLS-mCherry cells 
was seeded into two arrays and incubated for 16 h to allow the cells to adhere.  After 16 h the 
media was exchanged and replaced with 1:1 Wnt-3a conditioned media and fresh DMEM 
and incubated for 36 h. After 36 h the arrays were stained with 500 ng/mL Hoechst 33342 in 
PBS for 15 min which was then replaced with fresh DMEM. The array was moved to an 
inverted microscope (TE-2000-U, Nikon Instruments Inc. Melville, NY) mounted with a 
custom fabricated collar to hold a 150 µm diameter needle (Roboz Surgical Instrument Co. 
Gaithersburg, MD) above the 4× objective. Array elements containing a single cell (as 
identified by the presence of a single fluorescent nucleus in the Hoechst channel) that 
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exhibited strong reporter activation (nuclear localization of mCherry fluorescence) were 
dislodged from the array as described previously.26 The released, magnetic microstructures 
were collected individually with a permanent magnet and transferred to separate wells in a 
96-well plate, each containing 100 µL of expansion media (50% A375 conditioned media, 
25% fresh DMEM and 25% FBS). A375 conditioned media was prepared by sterile filtering 
20 mL of DMEM which had been overlaid on a T75 flask seeded with A375 cells at 50% 
confluence and aspirated after incubation for 48 h. Media was exchanged every 72 h until 
expanding colonies greater than 1 mm in diameter were observed. The colonies were then 
released with 0.15% trypsin and transferred to a 6-well plate for further expansion in 
standard DMEM. After 3 weeks of total expansion, cells were present at sufficient density to 
passage and aliquots were cryopreserved in FBS with 10% DMSO. A total of 6 monoclonal 
cell lines were generated and maintained for characterization. Fresh aliquots of monoclonal 
cells were used for at least 1 passage after thawing and within 3 passages after thawing. 
4.2.6 Single Cell Tracking and Reporter Dynamics Measurement 
All 6 monoclonal A375-BAR-mCherry cell lines were screened on 3 cell culture 
substrates: tissue culture treated polystyrene (TC), fibronectin (Fbn) and gelatin (Gel). To 
prepare the fibronectin-coated surface, wells of a tissue culture treated 96-well plate were 
incubated at 25 °C in 50 µL of 20 µg/mL of human plasma fibronectin (EMD Millipore, 
Billerica, MA) for 1 h then rinsed 3× with PBS before use. Gelatin coated wells were 
prepared by incubating at 25 °C in 0.1% gelatin in water (EMD Millipore) for 1 h, then 
rinsed 3× with PBS before use. 1000 cells from each monoclonal line were seeded into two 
wells each with identical surface treatments containing 100 µL of DMEM and incubated for 
16 h to allow the cells to adhere and stabilize. The media was aspirated and replaced with 50 
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µL of DMEM with 1 µg/mL of recombinant Wnt-3a and 250 ng/mL of Hoechst 33342 and 
incubated at 37 °C for 2 h. In control wells, media was replaced with DMEM containing 250 
ng/mL of Hoechst 33342 and a volume of 0.1% BSA in water identical to the volume added 
in media containing Wnt-3a. After 2 h the media was aspirated, the wells rinsed gently 3× 
with warm PBS (37 °C) and replaced with 100 µL of fresh DMEM and 250 ng/mL of 
Hoechst 33342. The 96-well array was then transferred to an inverted microscope (IX-81, 
Olympus America, Center Valley, PA) enclosed in a custom fabricated black Delrin housing 
with temperature, humidity (AirTherm ATX-H, World Precision Instruments, Sarasota, FL) 
and CO2 (ProCO2, BioSpherix, Lacona, NY) regulation maintained at 37 °C, 60% relative 
humidity and a 5% CO2 atmosphere. The inverted microscope was outfitted with a motorized 
XY stage (MS-2000, Applied Scientific Instrumentation, Eugene, OR), a metal arc lamp 
excitation source (Lumen 200, Prior Scientific, Rockland, MA), high speed shutter (Lambda 
10-2, Sutter Instrument Company, Novato, CA) and cooled interline CCD camera (CoolSnap 
HQ2,  Photometrics, Tucson, AZ). Multiple positions within each well were imaged at 10× 
magnification in the Hoechst and mCherry channels every 10 min for 62 h using the 
multidimensional acquisition tool in the open source microscope control software, Micro-
Mananger.27 A reference well was seeded with beads containing a fluorescent standard 
(MultiSpeck, Life Technologies) and was also imaged every 10 min in both channels.  
 The Hoechst channel image at each position and time-point was segmented using a 
custom pipeline implemented in CellProfiler28. Briefly, background fluorescence in the 
image was estimated by grayscale morphological opening and subtracted from the original 
image. The image was then smoothed with a 6 pixel median filter to reduce over 
segmentation of nuclei. The smoothed image was then converted to a black and white image 
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with a threshold determined by the  two-class implementation of Otsu’s method29 and 
segmented nuclei were declumped using a watershed method based on the shape of the 
detected nuclei. The segmented images were then exported with each object labeled by a 16-
bit integer number for tracking. A custom tracking script was implemented in MATLAB 
(The Mathworks Inc. Natick, MA) using the overlap method. Briefly, the intersection of 
every time-adjacent pair of images was calculated and nuclei in each image were assigned a 
shared label with the segmented nuclei from the previous time-point with which it shared the 
largest overlap. A second search was implemented to identify nuclei which shared no overlap 
with a nucleus in a previous time-point by searching for unmatched nuclei within a 20 µm 
neighborhood from the detected nucleus’ position. In cases where no match was found by 
overlap or distance (for example when a cell migrated from outside of the field of view), a 
new label was generated and used to track that object in subsequent frames although 
measurements were only made for cells that could be tracked uninterrupted over all time-
points. The labeled images of cell nuclei were then dilated by 5 pixels and used to integrate 
fluorescence in the mCherry channel for each corresponding nucleus at each time-point. 
Images of the reference well containing fluorescence standard beads were segmented in both 
channels using an empirical threshold and the mean fluorescence density (object intensity / 
object area in pixels) of the beads in each channel were measured at each time-point to 
control for variations in arc lamp intensity.  
4.2.7 Array Scan Automation 
 Microfabricated arrays were scanned using an automated software utility that 
provided a customized interface to the µManager microscope control libraries. Array 
scanning required four steps: user input of the array geometry (number of rows and columns, 
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array element dimensions), user-assisted localization of 2 opposing or 3 adjacent array 
corners, user-assisted focus at 4 or more positions in the array to calculate the plane of best 
fit and the sequential imaging of each field of view within the array. Images from each field 
of view were segmented based on the position of each microstructure which was calculated 
by interpolating from the user-identified corner positions and images of each individual 
microstructure were saved separately for image analysis. 
4.2.8 Clonogenic Screening 
Microfabricated cell arrays (110×110 array, rows × columns, 200×200×35 µm 
elements, length × width × height) were fabricated and prepared as previously described 
(detailed methods provided in supplement).30,31 For clonogenic screening, the arrays were 
mounted in custom cassettes fabricated by 3D printing polylactic acid with a convention 
fusion deposition modeling printer (BFB-3000, Bits from Bytes Ltd, now 3D Systems Inc. 
Rock Hill, SC) by gluing with a small amount of PDMS. The mounted arrays were sterilized 
by rinsing with 75% ethanol in water and air-dried prior to coating with fibronectin. The 
fibronectin coating was prepared by incubating the arrays in 20 µg/mL fibronectin in PBS for 
2 h at 25 °C. The arrays were then rinsed 3× with PBS and immediately seeded with cells.  
A total of 3,000 cells from the polyclonal A375-BAR-mCherry line were seeded onto 
each of 4 arrays and incubated for 16 h. After 16 h, the media was exchanged and the cells 
were incubated in 500 ng/mL of Hoechst 33342 in DMEM for 15 min at 37 °C and rinsed 3× 
with PBS. Two arrays were overlaid with DMEM containing 1 µg/mL of recombinant Wnt-
3a and 2 arrays were overlaid with DMEM containing 5 µM CT 99021. The arrays were 
immediately scanned at 4× magnification to measure Hoechst and basal mCherry 
fluorescence. After scanning, the arrays were incubated for 36 h at 37 °C, rinsed 3× with PBS 
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and incubated in DMEM containing 500 ng/mL of Hoechst 33342 in DMEM for 15 min at 
37 °C. The arrays were again rinsed 3× with PBS and immediately scanned. After an 
additional 36 h, the arrays were re-stained with Hoechst 33342, rinsed and the media was 
replaced prior to scanning. The media was exchanged 48 h later but the arrays were not 
scanned. A total of 5 d after the previous scan and after single cells on the array had 
expanded into colonal colonies, the media was exchanged, the arrays stained with Hoechst 
33342, and overlaid with solutions of recombinant Wnt-3a and CT 99021 as described above 
and the arrays were again scanned. After 36 h, the arrays were rinsed, stained and overlaid 
with DMEM prior to the final scan. Images from scanned arrays were segmented using the 
CellProfiler pipeline described above with parameters empirically adjusted to account for the 
higher background fluorescence from the photoresist substrate and lower magnification of 
the images. The integrated mCherry fluorescence was processed in terms of fluorescence 
density (RFU / pixel) using MATLAB since the mean fluorescence density of a colony will 
not be affected by under or over-segmentation errors caused by densely clustered cell nuclei. 
The purity of monoclonal colonies was assessed by manually inspecting the images of 25 
microstructures on each array which had at least 2 adjacent microstructures with no cells at 
the first time-point of the experiment.  
4.3 Results and Discussion 
4.3.1 Description of BAR-mCherry Reporter  
 Monoclonal cell lines are widely utilized in quantitative biomolecular and biophysical 
assays in an attempt to reduce biological variability as a source of noise.19–23 The generation 
of monoclonal cell lines requires the expansion of single cells over tens of generations to 
provide a sufficiently large number of cells to process using conventional tissue culture 
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techniques. The evolution of monoclonal cell lines over these timescales has not been well 
characterized. To characterize a reporter system in monoclonal cell lines, A375 cells were 
infected with a β-catenin activated reporter (BAR) driving expression of a nuclear 
localization signal-tagged mCherry red fluorescent protein (NLS-mCherry). The BAR-
mCherry reporter utilizes 12× TCF/LEF binding sites upstream of an NLS-tagged mCherry 
construct to function as a readout for Wnt/β-catenin signaling (Figure 4.1A). In A375-BAR-
mCherry cells, NLS-mCherry is not produced at levels detecTable 4.by fluorescence 
microscopy (Figure 4.1B) until treatment with Wnt3A ligand (Figure 4.1C).  The nuclear 
localization signal leads to accumulation of mCherry in the nucleus, simplifying automated 
image analysis as only segmentation of the nucleus is required to quantify mCherry 
fluorescence. 
4.3.2 Variability in Wnt Signaling Reporter Activity 
Six monoclonal cell lines were generated from a polyclonal population of A375 cells 
transfected with BAR-mCherry for the characterization of reporter dynamics. These clones 
were expanded over multiple generations (3 weeks, >25 generations) on a conventional 
polystyrene surface to populations large enough to be passaged and manipulated 
conventionally and the dynamics of reporter activation were measured at the single cell level 
within each clone.  Cells were tracked for 62 h with or without a brief treatment of 
recombinant Wnt-3a (1 µg/mL, 2 h). The production of mCherry over time was measured 
from a total of 1,895 treated cells (Figure 4.7) and 781 untreated cells (Figure 4.8) cultured 
on polystyrene by fluorescence microscopy and single-cell tracking. 
Significant variability was observed in both the kinetics (Figure 4.2A) and magnitude 
(Figure 4.2B) of Wnt reporter activation between A375-BAR-mCherry clones, however the 
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magnitude of activation (12 pair-wise differences, p < 0.01, p-values listed in Table 4.1) was 
seen to vary more between clones than the kinetics of activation (6 pair-wise differences, p < 
0.01, p-values listed in Table 4.2). Clone 2 was observed to be the most unique of all 6, 
showing significant differences in the median magnitude of activation and the time to reach 
peak activation relative to all other clones tested. Clones 1, 3, 5 and 6 exhibited pairwise 
differences in their median peak magnitude of activation between all but one other clone with 
similarities observed between clones 1 and 3 and clones 5 and 6. The kinetics of activation 
varied minimally in clones 2 through 6, with the only additional pair-wise difference existing 
between clones 2 and 4. The signal relaxation kinetics of single A375-BAR-mCherry cells, 
while highly varied (µ = 6.5 h, σ = 5.6 h), did not exhibit many differences between clones 
(Figure 4.2C). Only 2 statistically significant pair-wise differences were observed in the 
median time for signal to relax to half peak fluorescence (p < 0.01, p-values listed in Table 
4.3); between clones 2 and 4 and clones 4 and 6. The activation kinetics, peak activation 
magnitude and signal relaxation rate of BAR-mCherry are believed to be a function of 3 
basic processes: induction of Wnt signaling and activation of the BAR-mCherry reporter, 
synthesis and nuclear transport of NLS-mCherry and the non-specific proteasomal 
degradation of NLS-mCherry. In addition to significant intraclonal variability in the 
magnitude and kinetics of reporter activation and inactivation, the interclonal variability 
observed (primarily in peak activation magnitude and to a lesser extent in activation kinetics) 
is suggestive of the presence of fundamental differences in Wnt signaling, transcriptional, 
translational and degradation phenotypes between individual monoclonal cell lines. 
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4.3.3 Variations in Reporter Dynamics Are Regulated by Independent Processes 
Hoechst fluorescence, a measure of DNA concentration, and reporter activation 
kinetics were not correlated with reporter activation magnitude for any individual clone 
(Table 4.4) or for the measurements of all clones pooled together (Figure 4.3A, B). The 
nuclear size and Hoechst fluorescence intensity of cells was observed to vary significantly 
even within monoclonal populations, indicative of aneuploidy. Wnt signaling is modulated 
during the cell cycle32,33, however it is not possible to correlate progression through the cell 
cycle with DNA concentration measured by Hoechst fluorescence in an aneuploid 
population. In comparing the mean intensity of nuclear Hoechst fluorescence over the course 
of the experiment against the peak activation magnitude (Figure 4.3A), no correlation 
between the two measurements was seen for any of the clones (r2 = 0.09). Thus the amount 
of DNA present in each cell did not appear to influence the magnitude of reporter activation 
and the magnitude of reporter activation was independent of DNA content or degree of 
aneuploidy. The kinetics of activation (as measured by the time require to reach peak 
fluorescence intensity) were also uncorrelated with the magnitude of activation (r2 = 0.15; 
Figure 4.3B). While the rate of signal accumulation varied significantly from cell-to-cell, it 
was not dependent on or influenced by the activation magnitude of the reporter. This 
suggests that the rate and magnitude of reporter activation were regulated by distinct 
processes. It is likely that the rate of signal accumulation was a function of the kinetics of 
NLS-mCherry translation and degradation while the magnitude of reporter activation was a 
function of the fold-change in the nuclear concentration of β-catenin.15 The signal relaxation 
kinetics of all 6 clones varied widely from cell to cell, but was observed to be uncorrelated 
with either peak activation magnitude (Figure 4.3C, r2 = 0.01) or the time required to reach 
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peak activation (Figure 4.3D, r2 = 0.006). In tumor cells, non-specific proteasomal 
degradation likely dictates the reporter signal decay rate due to the critical role protein 
degradation plays in survival.34–36 In totality, these observations strongly support the 
interpretation that the kinetics of reporter activation, the magnitude of reporter activation and 
the kinetics of signal relaxation were independently regulated and highly variable processes 
in A375-BAR-mCherry. While we could not test for correlations between cell cycle and 
reporter activation magnitude, Hoechst fluorescence, a measure of DNA concentration was 
not correlated with reporter activation magnitude. 
4.3.4 Matrix-dependence of Wnt/β-catenin Reporter Activation 
The influence of extracellular matrix (ECM) mediated signaling on the reporter 
phenotype was also characterized for each clone as a potential indicator of inter-clonal 
phenotypic variability as integrin signaling is known to promote Wnt activity.37–40 
Differential integrin binding to polystyrene, gelatin and fibronectin surfaces was expected to 
produce different degrees of reporter modulation in cells treated with Wnt. Three culture 
substrates were evaluated: tissue-culture polystyrene, human-plasma fibronectin, and gelatin. 
Cells cultured on each substrate were tracked for 62 h with or without a brief treatment of 
recombinant Wnt-3a (1 µg/mL, 2 h). The production of mCherry over time was measured 
from a total of 5,598 treated cells (Figure 4.7) and 2,647 untreated cells (Figure 4.8) by 
fluorescence microscopy and single-cell tracking. Reporter activation kinetics, peak 
activation magnitude and signal relaxation kinetics for cells cultured on fibronectin and 
gelatin were observed to be similarly uncorrelated as compared to cells cultured on 
polystyrene (Figure 4.S3A-C). Reporter activation magnitude was also similarly uncorrelated 
with mean Hoechst fluorescence (Figure 4.S3D). This further reinforces our conclusion that 
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these components of overall reporter dynamics are independent of each other as well as of 
ECM-mediated effects on Wnt signaling in A375-BAR-mCherry. 
While significant intraclonal heterogeneity was present in all clones on all cell culture 
substrates in terms of reporter activation kinetics (Figure 4.4A) and relaxation kinetics 
(Figure 4.4C), the ECM did not possess a strong impact on these attributes in most clones. In 
terms of reporter kinetics, activation rates (Figure 4.4A) exhibited a dependence on cell 
culture substrate in only two clones (p < 0.01, p-values listed in Table 4.5), while signal 
relaxation rates (Figure 4.4C) exhibited no dependence on ECM interactions (p < 0.01, p-
values listed in Table 4.6). Within clones 3 and 4, a statistically significant difference was 
observed in the time required to reach peak mCherry fluorescence between cells cultured on 
fibronectin and cells cultured on gelatin. Within clone 4, a difference was also observed in 
the time required to reach peak fluorescence between cells cultured on polystyrene and cells 
cultured on gelatin. The presence of only 3 statistically significant pair-wise differences out 
of 12 comparisons in the dependence of reporter activation kinetics on ECM interactions 
demonstrated that that intraclonal variability in reporter activation and signal relaxation 
kinetics was generally much greater than the variability caused by ECM-dependent 
interactions. 
 In contrast to activation and relaxation kinetics, reporter activation magnitude was 
observed to depend on cell culture substrate (Figure 4.4B) with significant variations in 
magnitude both within and between clones (12 pair-wise differences out of 18 comparisons, 
p < 0.01, p-values listed in Table 4.7). For clones 1-3, cells cultured on fibronectin reached a 
significantly higher peak fluorescence intensity (p < 0.01, p-values listed in Table 4.8) than 
on polystyrene or gelatin. Clones 4-6 departed from this trend, again suggesting the presence 
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of distinct signaling phenotypes within the A375-BAR-mCherry population from which the 
clones were selected. 
4.3.5 Characterization of Reporter Cell Lines by Clonogenic Screening 
The dangers of phenotypic and genetic drift of in-vitro cultured cell lines over time 
have been widely discussed.41,42 In light of the time required to expand monoclonal cell lines 
to sufficient size for manipulation with conventional cell culture techniques, there is some 
question as to whether the heterogeneity observed in reporter systems for Wnt/β-catenin 
signaling are inherent to the pathway, artifacts of the reporter, a product of long-term drift or 
a combination of all three. Regardless of the origins of this diversity, there are significant 
practical implications for the use of monoclonal cell lines and transcriptional reporters.  
Studying monoclonal colonies a smaller number of generations removed from the originating 
mother cell could reduce the impact of long-term phenotypic drift and provide evidence as to 
the origins of inter- and intra-clonal heterogeneity, but would also reduce the statistical 
power of measurements made on the smaller number of cells available. Analyzing a large 
number of monoclonal colonies in parallel would enable statistical comparisons to be made 
while also increasing the likelihood of capturing a representative sample of the diverse 
signaling phenotypes which may be present. To characterize the diversity of monoclonal 
colonies early in their evolution, we screened a large number of A375-BAR-mCherry clones 
in a massively parallel fashion using microfabcricated cell arrays.43–45 With these arrays, cells 
are prevented from migrating between adjacent microstructures by a long-lived intervening 
air bubble.31 The maintenance of clonal isolation was assessed by manually examining 25 
microstructures and their neighboring unoccupied microstructures on each of 4 arrays (100 
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microstructures in total) over 8 days. Across all 100 positions examined and over the 8 days, 
no cells ever appeared on microstructures that were unoccupied on day 1.  
The clonogenic screen consisted of 3 steps: an initial activation assay on single A375-
BAR-mCherry cells after 16 h of culture on cell arrays, a 5 day expansion period in which 
the single cells grew into monoclonal colonies and a final activation assay performed on the 
monoclonal colonies at day 8 of culture (Figure 4.5). The activation assays were performed 
by addition of Wnt-3a or CT99021 (an inhibitor of GSK3β) to the arrayed cells followed 
imaging of Hoechst and mCherry fluorescence 36 h later.  The 5-day expansion period was 
selected so that colonies could undergo up to 6 rounds of cell division (A375 doubling time is 
<20 h46). By assaying both single A375-BAR-mCherry cells and their clonal progeny, 
reporter activation of the clones could be correlated to the activity of the mother cell to track 
divergence.  In addition to imaging the arrays for mCherry expression before and after the 
initial and final activation assays, a scan was performed 36 h after completion of the first 
activation assay to track signal relaxation; however, no cells were observed to be detectably 
more fluorescent than basal levels at this time-point. A total of 1,119 clones were assayed 
over four arrays. Of these, 684 clones were tracked on two arrays treated with Wnt-3a and 
435 clones were tracked on two arrays treated with CT 99021. 
4.3.6 Evidence of Cell Division-Dependent Wnt Signaling Feedback 
On average, daughter cells treated with Wnt-3a (Figure 4.6A) showed 13.9% lower 
peak fluorescence relative to their corresponding mother cells. Reporter activation magnitude 
was observed to vary with the number of cell divisions a colony underwent in A375-BAR-
mCherry clones treated with Wnt-3a (Figure 4.6A, C). Cells which were viable but remained 
non-proliferative (corresponding to 0 divisions) exhibited significantly (p < 0.01) weaker 
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mCherry fluorescence during the second treatment step relative to the first treatment. Cells 
that did not divide did not exhibit detectably greater basal levels of activation prior to the 
second treatment. This observation directly supports previous evidence of the self-inhibition 
by Wnt/β-catenin pathway activation47 (Figure 4.1A). Multiple downstream gene targets of 
β-catenin include Wnt signaling inhibitors such as DKK48, which causes Frizzled receptor 
internalization, β-transducin repeat containing protein49 (β-TrCP), which mediates 
ubiquitination of phosphorylated β-catenin, and Axin250, a key scaffold for the destruction 
complex.  
Cell division or associated signaling processes regulate Wnt self-inhibition. Colonies 
treated with Wnt-3a that underwent multiple cell divisions (>2) exhibited significantly 
increased reporter activation levels relative to the overall population (Figure 4.6C; p < 0.01). 
A number of positive feedback loops for Wnt pathway activation have been identified with 
oncogenic implications.51–54  These feedback loops regulate Wnt signal transduction at both 
the receptor and destruction complex level and can lead to increased β-catenin expression 
levels. The link between positive feedback and cell division is less clear although several of 
the signaling pathways responsible for positive feedback in Wnt signaling are also tied to 
proliferative phenotypes including hepatocyte growth factor receptor51,55 (HGFR), 
extracellular signal-regulated kinases52 (ERK), c-Myk56 and phospholipase D154 (PLD1). The 
observed correlation with cells undergoing multiple divisions (Figure 4.6C) suggests that 
increased proliferation may be an effect of increased feedback activity from these or other 
Wnt signaling partners rather than a cause. At least some of the heterogeneity we observed 
can likely be attributed to epigenetic silencing or activation of reporter integration sites57, 
however epigenetic silencing of the reporter should be randomly distributed over a 
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sufficiently large number of sub-clones and should not exhibit a bias that is dependent on the 
point of pathway activation or cell division.  
4.3.7 Inhibition of GSK3β Removes Cell Division-Dependence of Reporter Activation 
In A375-BAR-mCherry clones treated with CT99021, reporter activation magnitude 
was seen to decrease by an average of 8.34% relative to the activation magnitude of the 
mother cells. Reporter activation magnitude did not vary with the number of divisions a 
colony underwent (Figure 4.6B, D). The lack of a trend in clones treated with CT99021 (p > 
0.01, Figure 4.6D) agrees with proposed mechanisms of Wnt self-inhibition as this feedback 
is integrated at or before the level of the destruction complex. Since GSK3β inhibition 
directly inhibits the function of the destruction complex, desensitization to Wnt by increased 
expression of DKK, β-TrCP or Axin2 in cells would have no effect on the induction of 
signaling in cells treated with CT 99021. Positive feedback was also not evident in colonies 
treated with CT99021 as the distribution of the fold-change in reporter activation magnitude 
was homogenous with respect to the number of cell divisions each colony underwent (Figure 
4.6D). Since the known mechanisms of Wnt sensitization and positive feedback also function 
at or upstream of the destruction complex, their effects on reporter activation by treatment 
with CT 99021 would be expected to have been significantly reduced. While increased β-
catenin expression levels might still result in positive feedback, recent evidence suggests that 
Wnt signaling is defined by a fold-change in nuclear β-catenin concentration, not the absolute 
concentration and the magnitude of reporter activation we observed was likely dominated by 
the activity of CT 99021.15  
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4.4 Conclusions 
Our observations present a cautionary tale regarding the reliance on monoclonal cell 
lines as reporter systems for the study of intracellular signaling. Conventional in-vitro 
reporter-based assays probe simplified systems in which the dynamics of cellular signaling 
and interactions are suppressed or reduced through strategies such as the generation of 
monoclonal cell lines, however this is fraught with risk. We observed the selection of distinct 
signaling phenotypes in the generation of monoclonal cell lines which may represent (or 
miss) rare subpopulations in the polyclonal population or which may not exist in-vivo. In the 
characterization of ECM-dependent modulation of reporter activation, we observed 
significant differences in the pattern of signal enhancement and inhibition between clones. 
As extracellular signaling is integrated into Wnt signaling through multiple intermediates37–
40, it is possible that these distinct phenotypes may be defined by differences in expression 
levels or mutations in intermediate signaling cascades or receptor signaling complexes. This 
is an alarming observation for signaling investigations which rely on monoclonal cell lines as 
characterization of individual clones with different signaling phenotypes could lead to 
seemingly contradictory observations. For example, selection of a single clone could provide 
evidence that fibronectin-mediated integrin signaling enhances Wnt-induced reporter 
activation (eg. clone 1) or, if a different clone had been selected, the same experiments could 
suggest the opposite relationship (eg. clone 5). The use of single monoclonal cell lines should 
thus be avoided in the study of signaling pathways as phenotypes and interactions identified 
may vary significantly between different clones, even those prepared from the same cell line, 
reducing the generalizability of findings and making their replication challenging. We 
observed reporter activation levels diverge within 5 generations of the isolation of clonal 
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populations over a 2-log range (0.1-10× the relative signal response of the mother cells). This 
range matches closely with observations in a different biological and reporter system for β-
catenin5, suggesting that our observations are not unique to A375-BAR-mCherry. Single-cell 
resolution measurements of polyclonal populations are likely a more robust platform for 
screening and discovery. Combining single-cell measurements with a platform for 
performing cell isolations, such as arrays of releasable microstructures, would allow sub-
populations exhibiting distinct phenotypes to be separated and further studied. This would 
enable a more robust and complete characterization of heterogeneous samples without bias 
towards specific phenotypes which may be present.   
Our observations strongly support the existence of both positive and negative 
feedback in Wnt/β-catenin signal activation, at least in the A375 cell line. The observation of 
changing signaling phenotypes in cells stimulated with Wnt-3a over different colony sizes 
suggests a potential role of cell division or a combination of associated molecular signaling 
events in modulating both the negative and positive self-regulation of Wnt signaling. To 
perform a clonogenic screen on the scale that was presented here by limiting dilution would 
require an average of 3,042 wells to be seeded, consuming eight 384-well plates, 245.8 mL 
of media per exchange and 245.8 µg of Wnt-3a. Cell array technology enables the rapid 
performance of a massively parallel clonogenic screen with comparatively little reagent 
consumption; in ideal cases up to a 99.5% reduction in reagent consumption on a per-clone 
basis relative to well-plate screening (Table 4.9). Additionally, the ability to sort individual 
selected clones can be utilized in future studies to trace the mechanisms of emergent 
heterogeneity as well as in the identification of novel regulators of Wnt signaling. 
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Our observation of multiple clones with diverse signaling phenotypes within a single 
cell line (Figure 4.2A & B) highlights the risks of artificially reducing diversity within a 
reference population, particularly for tumor cells which are known to host diverse 
subpopulations.6,7 High throughput screens20,21,58, fundamental investigations of intracellular 
signaling59,60 and single-cell measurements8,19 performed using a small number of clones 
could be dramatically affected by the unintentional selection of distinct phenotypes and their 
results may prove difficult to reproduce or contradictory to the investigations of other groups 
as a consequence, despite their accuracy within their respective reference systems. 
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4.5 Figures 
 
Figure 4.1. Overview of BAR-mCherry reporter. (A)  Simplified schematic of BAR-mCherry 
integration into the canonical Wnt/β-catenin signaling cascade. (i) Wnt-3a binding to Frizzled 
results in inhibition of the destruction complex. (ii) β-catenin translocated to the nucleus 
drives gene expression in concert with TCF/LEF transcription factors. (iii) BAR-mCherry is 
produced from active β-catenin signaling and builds up as long as production exceeds 
degradation. (iv) Downstream targets of Wnt include several of its own regulators including 
Axin and β-TrCP which mediate β-catenin degradation and DKK which causes Frizzled 
receptor internalization. Example images showing A375-BAR-mCherry cells treated with L-
cell conditioned media (no Wnt-3a) (B) and Wnt-3a conditioned media (C) for 24 h. Nuclei 
are counterstained with Hoechst 33342 (blue) to show nuclear localization of NLS-mCherry 
(red, merge = pink). Scale bar is 100 µm. 
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Figure 4.2. Box and whisker plots showing the characterization of A375 clones. (A) Times 
required to reach peak fluorescence, (B) the peak mCherry fluorescence achieved and (C) the 
time required for signal to decay to half peak fluorescence for single A375-BAR-mCherry 
cells cultured on polystyrene. Red circles mark the population mean for each distribution. 
Outliers shown are observations above the 5th and below the 95th percentile. The boxes mark 
the 25th, 50th (median) and 75th percentiles within the distribution while the whiskers mark 
the 5th and 95th percentiles.  
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Figure 4.3.  Comparisons between measured parameters from single-cell tracking of A375-
BAR-mCherry cells (all 6 clones are shown pooled together) cultured on polystyrene after 
treatment with Wnt3a. (A) Peak mCherry fluorescence achieved versus the mean Hoechst 
fluorescence over the 62 h time-course (r2 = 0.09) (B) Peak mCherry fluorescence versus the 
time required to reach peak fluorescence (r2 = 0.15) (C) Peak mCherry fluorescence achieved 
versus the time required for signal to decay to half peak fluorescence (r2 = 0.01) (D) The time 
required for signal to decay to half peak fluorescence versus the time required for cells to 
reach peak fluorescence (r2 = 0.006). 
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Figure 4.4. Characterization of BAR-mCherry reporter relaxation. Box and whisker plots 
showing the distributions of (A) the times to reach peak mCherry fluorescence, (B) the peak 
mCherry fluorescence intensity achieved and (C) the time required for signal to decay to half 
peak mCherry fluorescence for single A375-BAR-mCherry cells cultured on polystyrene 
(clear boxes), fibronectin (dark gray boxes) and gelatin (diagonal striped boxes). Red circles 
mark the population mean for each distribution. Outliers shown are observations above the 
5th and below the 95th percentile. The boxes mark the 25th, 50th (median) and 75th percentiles 
within the distribution while the whiskers mark the 5th and 95th percentiles. 
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Figure 4.5. Process flow for the parallel clonogenic screen on the arrays. The experiment 
begins by seeding a single cell suspension of A375-BAR-mCherry cells onto the arrays. 
After 16 h the arrays are scanned to measure basal mCherry expression and then treated with 
either Wnt-3a or CT 99021. 36 h after treatment, the array is washed and scanned again to 
measure peak mCherry fluorescence activation. After an additional 36 h, the array is again 
scanned to track the relaxation of the mCherry signal. 84 h following the relaxation scan, the 
array is again scanned to confirm that the cells have reached basal activation levels and 
treated again with Wnt-3a or CT 99021. 36 h post-treatment, the arrays are washed and 
scanned again to measure peak mCherry fluorescence.  Shown below the process flow is a 
series of images taken of a single clone over the course of the experiment. Hoechst 33342 
and mCherry fluorescence is shown in blue and red, respectively.  
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Figure 4.6. Distribution of the mean fold change in fluorescence density (RFU / pixel) 
between each clonal colony in the final time point and its corresponding mother cell for 
arrays treated with (A) Wnt-3a and (B) CT 99021. The bar color marks the nearest whole 
number of divisions each clonal colony underwent. Bar charts showing the mean fold-change 
for cells in each corresponding number of divisions for cells treated with (C) Wnt-3a and (D) 
CT 99021. Error bars show the standard error of the mean. Red line marks the total 
population mean. Asterisks mark populations found to be significantly different from the 
population mean (p < 0.01). Bars are not shown for colonies with >4 divisions due to an 
insufficient number of colonies greater than that size. 
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Figure 4.7. Traces showing the dynamics of mCherry fluorescence after stimulation of 6 
clonal A375-BAR-mCherry cell lines with 1 µg/mL recombinant Wnt-3a for 2 h.  
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Figure 4.8. Traces showing measurement of mCherry fluorescence in control A375-BAR-
mCherry cells treated with the vehicle for recombinant Wnt-3a (0.1% BSA in DI water stock 
concentration) for 2 h. 
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4.6 Tables 
 Clone 1 Clone 2 Clone 3 Clone 4 Clone 5 Clone 6 
Clone 1 1 1.14E-14 0.054695 5.74E-10 8.91E-09 3.74E-13 
Clone 2 1.14E-14 1 5.49E-06 1.69E-29 2.05E-29 1.88E-22 
Clone 3 0.054695 5.49E-06 1 3.77E-10 9.86E-10 4.37E-13 
Clone 4 5.74E-10 1.69E-29 3.77E-10 1 0.155183 0.294269 
Clone 5 8.91E-09 2.05E-29 9.86E-10 0.155183 1 0.000509 
Clone 6 3.74E-13 1.88E-22 4.37E-13 0.294269 0.000509 1 
 
Table 4.1. P-values for the two-tailed Wilcoxon rank sum test comparing the median peak 
reporter activation magnitude between each pair of clonal A375-BAR-mCherry cell lines 
cultured on polystyrene. Pair-wise comparisons that were found to be significant (α = 0.01) 
are shown in bold. 
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 Clone 1 Clone 2 Clone 3 Clone 4 Clone 5 Clone 6 
Clone 1 1 5.69E-05 0.000226 1.43E-10 3.65E-10 5.57E-06 
Clone 2 5.69E-05 1 0.789757 0.006017 0.041012 0.495437 
Clone 3 0.000226 0.789757 1 0.057556 0.174166 0.625638 
Clone 4 1.43E-10 0.006017 0.057556 1 0.407026 0.113721 
Clone 5 3.65E-10 0.041012 0.174166 0.407026 1 0.355528 
Clone 6 5.57E-06 0.495437 0.625638 0.113721 0.355528 1 
 
Table 4.2. P-values for the two-tailed Wilcoxon rank sum test comparing the median time to 
reach peak reporter activation between each pair of clonal A375-BAR-mCherry cell lines 
cultured on polystyrene. Pair-wise comparisons that were found to be significant (α = 0.01) 
are shown in bold. 
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 Clone 1 Clone 2 Clone 3 Clone 4 Clone 5 Clone 6 
Clone 1 1 0.057693 0.450691 0.038412 0.576431 0.099773 
Clone 2 0.057693 1 0.740352 0.001893 0.169575 0.971958 
Clone 3 0.450691 0.740352 1 0.044307 0.657881 0.787086 
Clone 4 0.038412 0.001893 0.044307 1 0.010573 0.002302 
Clone 5 0.576431 0.169575 0.657881 0.010573 1 0.246888 
Clone 6 0.099773 0.971958 0.787086 0.002302 0.246888 1 
 
Table 4.3 P-values for the two-tailed Wilcoxon rank sum test comparing the median time to 
reach half peak reporter activation between each pair of clonal A375-BAR-mCherry cell 
lines cultured on polystyrene. Pair-wise comparisons that were found to be significant (α = 
0.01) are shown in bold. 
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Clone: 1 2 3 4 5 6 
Peak mCherry Fluorescence vs 
Mean Hoechst Fluorescence 
0.0342 0.0801 0.0932 0.1808 0.3903 0.0705 
Peak mCherry Fluorescence vs 
Time to Peak Fluorescence 
0.0008 0.0250 0.0156 0.0180 0.0004 0.0255 
Peak mCherry Fluorescence vs 
Time to Half Peak Fluorescence 
0.0001 0.0364 0.0355 0.0000 0.0047 0.0044 
Time to Peak Fluorescence vs 
Time to Half Peak Fluorescence 
0.0418 0.0162 0.0549 0.0012 0.0033 0.0078 
 
Table 4.4. R2 values for parameter comparisons between control measurements made on 
single cells from each monoclonal population of A375-BAR-mCherry cells cultured on tissue 
culture polystyrene. 
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Clone 1 2 3 4 5 6 
PS vs Fbn 0.015467 0.930512 0.067268 0.383456 0.469664 0.013488
PS vs Gel 0.683797 0.099148 0.856897 0.500818 0.55149 0.538264
Fbn vs Gel 0.048942 0.151066 0.043366 0.970127 0.249788 0.073528
 
Table 4.5. p-values for the two-tailed Wilcoxon rank sum test to evaluate the null hypothesis 
that the median times to reach half peak fluorescence are not different for each pair of cell 
culture substrates tested for each clone. At the α = 0.01 level, the test failed to reject the null 
hypothesis for all comparisons. 
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Table 4.6. P-values for the two-tailed Wilcoxon rank sum evaluating the null hypothesis that 
the median time to reach peak fluorescence for each test pair is not significantly different. 
The test failed to reject the null hypothesis for all but three cases for α = 0.01 level. In clones 
3 and 4, the median time to reach peak fluorescence for cells cultured on fibronectin was 
significantly longer than for cell cultured on gelatin and in clone 4 the median time was also 
significantly longer for cells cultured on fibronectin than for cells cultured on polystyrene. 
  
Clone 1 2 3 4 5 6 
PS vs Fbn 0.502104 0.275798 0.06618 0.00258 0.358901 0.341907
PS vs Gel 0.205828 0.284172 0.038567 0.793116 0.874622 0.411383
Fbn vs Gel 0.165635 0.048529 1.83E-05 0.005946 0.464554 0.657918
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Clone 1 2 3 4 5 6 
PS vs Fbn 1.42E-08 0.00057 2.55E-09 0.0412 9.71E-06 0.0269
PS vs Gel 0.02896 0.66139 8.16E-05 0.0032 0.00011 1.34E-11
Fbn vs Gel 1.72E-05 2.41E-09 1.29E-18 0.96308 0.37721 4.76E-05
 
Table 4.7. p-values for the two-tailed Wilcoxon rank sum test to evaluate the null hypothesis 
that the median intensity of each pair of conditions is not statistically significantly different. 
Values that fail to reject the null hypothesis at the α = 0.01 level are shown in bold. 
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Clone 1 2 3 4 5 6 
PS 7.10E-09 2.86E-04 1.27E-09 0.0206 1 0.987
Gel 8.59E-06 1.20E-09 6.47E-19 0.519 0.812 2.38E-05
 
Table 4.8.  p-values for the single-tailed Wilcoxon rank sum test to evaluate the null 
hypothesis that the median intensity of the fibronectin distribution is not greater than the 
median intensities of PS or Gel. At the α = 0.01 level, the rank sum test shows a statistically 
significantly higher median fluorescence intensity for Clones 1-3 when cultured on 
fibronectin than either of the alternate substrates and a high median fluorescence intensity for 
Clone 6 when cultured on fibronectin than on gelatin. 
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Format Ideal Clonal Yield 
Media Consumption 
per Clone (mL) 
Wnt-3a 
Consumption per 
clone (µg) 
384-well plate 141 ± 12 1.305 0.435 
Cell Array 4,047 ± 64 0.006 0.002 
Reduction  99.5% 99.5% 
 
Table 4.9. Comparison of reagent consumption and clonal yield of screening performed using 
conventional 384 well plates and a 1 in2 cell array containing 12,100 elements. Expected 
clonal yield was estimated using the Poisson distribution for a seeding ratio of 1 cell per well 
or array element; the error shown is the standard deviation of the Poisson distribution for the 
corresponding mean. Media consumption was calculated for 6 exchanges of 80 µL per well 
for the 384 well plate and 4 mL per cell array. Wnt-3a consumption was calculated for two 
80 µL doses of 1 µg/mL Wnt-3a for the 384 well plate and two 4 mL doses for the cell array. 
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Chapter 5: Conclusions 
 The primary goal of the work presented in this dissertation was the development of an 
integrated platform for sorting single adherent cells and colonies based on imaging cytometry 
measurements. Towards this goal an imaging cytometry platform was developed which 
incorporated micropallet array technology with automated microscope control and imaging 
as a flexible base upon which applications of imaging cytometry and micropallet array 
sorting could be implemented. While sorting capabilities of the designed system are currently 
limited only to micropallet arrays, the cytometry functions of the platform can be applied to a 
variety of microfabricated array modalities including microwell arrays and microraft arrays. 
Indeed, one of the key areas for future development of this platform will be the incorporation 
of functionality allowing for the automated release and collection of microrafts.  
 The work presented here covered three major aspects of developing and 
demonstrating this integrated platform including materials development (Chapter 2), system 
development and integration (Chapter 3) and the demonstration of the unique capabilities of 
micropallet-array based cytometry (Chapter 4).  
5.1 The Development of a Novel Magnetic Photoresist for Micropallet Fabrication 
 While the primary goal of the work presented in Chapter 2 was to develop a scalable 
synthesis for a magnetic photoresist that could be used for micropallet array fabrication, the 
material developed has broader applications in the fabrication of magnetically active 
microdevices. Three key performance parameters were essential to the success of this 
material: optical clarity, tissue culture biocompatibility and magnetic functionalization. 
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Development of an optically clear photoresist depended on the sTable 4.dispersion of the 
magnetic colloid into the base photoresist. This proved challenging due to the incompatibility 
of solvent systems commonly utilized in nanoparticle synthesis and GBL, the solvent system 
used in the 1002F base photoresist. This was surmounted through a surface ligand exchange 
which replaced the hydrophobic coating used in the nanoparticle synthesis with a polymeric 
matrix comprised of PMMA/MMA which is soluble in GBL.1 PMMA/MMA was selected 
due to its excellent optical properties, demonstrated biocompatibility and the presence of 
epoxy-reactive carboxylic acid side-groups which would allow it to cross-link with the 1002F 
base photoresist. DSC confirmed the hypothesis that PMMA/MMA will form a single phase 
with 1002F and characterization of the resulting composite photoresist showed excellent 
photolithographic performance, achieving aspect ratios >10. MTT assays showed no 
significant effect on the metabolism of HeLa cells when grown on the new composite 
PMMA/1002F photoresist relative to glass. Primary murine mesenchymal stem cells were 
also shown to exhibit typical morphologies when cultured on the PMMA/1002F composite. 
The magnetic functionalization of the PMMA/1002F photoresist was also demonstrated by 
fabricating a micropallet array using it and successfully releasing clonal colonies of 
fluorescent HeLa cells (HeLa-H2B-GFP) from the array and collecting the released colonies 
against gravity using a solid state magnet. The excellent optical, mechanical and magnetic 
properties of the PMMA/1002F composite, as well as its excellent biocompatibility, made it 
a useful tool in microdevice fabrication. 
5.2 Micropallet Array Scan and Release Automation 
 The integration of micropallet array technology into an imaging cytometry platform 
require the development of three components: a fully computerized microscope platform, a 
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software utility for the automated imaging of microfabricated cell arrays and a software 
utility for the automated release of individual micropallets from an array. The first 
component was built using off-the-shelf components and incorporated a motorized 
microscope frame, motorized stage, computer-controlled shutters and cooled CCD camera. 
Both software utilities were developed using a common framework which relied upon the 
user to provide the data required to register a microfabricated array to the microscope’s stage 
coordinate system. The array’s geometry was first registered in the XY plane by the user-
assisted location of two opposing corners of the array and the input of the array’s physical 
geometry (number of rows and columns and the size and spacing of the array’s elements). 
From this information the position of every element within the array could interpolated to 
within 3 µm, an accepTable 4.error when considering the resolution of low magnification 
microscope objectives and the repeatability of motorized stage positioning.  The array’s 
orientation in the Z plane was then registered through the user initialization of a set of guide 
points. With a minimum of 4 points in the array located in X, Y and Z coordinates, a plane of 
best fit could be calculated using the singular value decomposition of the initialized 
positions. The flatness of the array surface meant that errors in the focus plane calculated 
were typically within the depth of focus of the objective utilized (<2 µm). With the 
initialization of these two data, the array could be rapidly scanned in an automated fashion by 
navigating to each calculated field of view within the array. To simplify image analysis and 
data processing, the image acquired at each field of view was segmented based on the 
interpolated position and the user-provided size of each micropallet and an individual image 
of each micropallet was saved. Metadata relating the relative position of each micropallet 
with the array was stored in the image filename, allowing data from multiple scans to be co-
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registered. The automation of micropallet array scanning and release was demonstrated with 
a simple application in which EpCAM+ cancer cells from a PDX tissue sample were purified 
from a background of EpCAM- contamination. This purification would be challenging to 
perform using conventional FACS and MACS due to the extremely small numbers of viable 
cell yielded from the PDX tissue samples. With micropallet arrays, however, three samples 
of 7,584, 1,087 and 875 cells each were successfully sorted, yielding 257, 16 and 7 EpCAM+ 
cells, respectively. Image analysis for this application was performed using a CellProfiler 
pipeline for segmentation and achieved a false-negative rate of 1%, 0% and 0% for the three 
sample sorted and a false-positive rate of 0%, 8% and 9%. This performance far exceeds that 
of MACS and FACS for samples 10× as large2 demonstrating both the value of micropallet-
array based isolations for small tissue samples that are often produced by animal model 
research and primary tissue biopsies as well as the successful integration of both automated 
imaging and automated release for micropallet arrays. 
5.3 Massively Parallel Clonogenic Screening with Micropallet Arrays 
 Advances in high throughput screening approaches and the development of robust 
transcriptional reporters for signaling have accelerated the pace of discovery for targeted 
therapies for cancer.3–5 The performance of these screens is highly dependent on the dynamic 
range and variability of the reporter utilized. While significant improvements have been 
made to luminescence and fluorescence-based readouts, little is understood about the 
dynamics of transcriptional reporter evolution. A common approach to reducing variability in 
transcriptional reporter cell lines is to generate monoclonal populations. Several groups have 
published data showing the emergence of heterogeneity in monoclonal cell lines6–9, and 
evidence exists for epigenetic silencing of reporter genes play a role10. In order to better 
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understand the dynamics of the reporter evolution process, 6 monoclonal reporter cell lines 
were developed using microraft array cloning of a cell line bearing a transcriptional for β-
catenin signaling (BAR-mCherry). These clonal cell lines were then stimulated with 
recombinant Wnt3a and the single-cell dynamics of signal activation and relaxation 
quantified. Single-cell tracking revealed distinct signaling phenotypes present in the 
monoclonal populations and a dependency of both signaling kinetics and magnitude on 
ECM-mediated signaling. In order to characterize a larger number of clones to better capture 
the dynamics of the original polyclonal cell line, micropallet arrays were used to conduct a 
massively parallel clonogenic screen. Single A375-BAR-mCherry cells seeded onto 
micropallet arrays were stimulated with either recombinant Wnt-3a or CT 99021, an inhibitor 
of GSK3β. The peak activation magnitude was measured of the individual cells after 
stimulation for 36 h and the stimulus was removed. After 5 days of expansion, the clonal 
colonies which grew from the individual mother cells were assayed in the same fashion. The 
screen revealed a 100-fold difference in the overall population in the range of the change in 
signaling magnitude relative to the mother cells within 6 rounds of cell division. 
Additionally, self-inhibitory signaling was directly observed in cells stimulated with Wnt-3a 
that remained viable but non-proliferative during the 5 day expansion period. This self-
inhibition disappeared in cells that divided and colonies that had passed 3 divisions exhibited 
positive feedback in signaling relative to their mother cells. The conclusion that the positive 
and negative feedback processes that were observed were not reporter artifacts is supported 
by the lack of an observed trend in colonies treated with CT 99021 which would bypass 
mechanisms of positive and negative feedback for Wnt-mediated β-catenin signaling 
described in the literature.11–16  
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In addition to these biological observations, this work suggests that phenotypic 
homogeneity rather than genotypic homogeneity is more important for the optimization of 
reporter systems in high throughput screening. Monoclonal selection will likely not only fail 
to reduce heterogeneous signaling intensity, but may bias the assay or screen due to the 
inclusion of an atypical signaling phenotype. Micropallet arrays were a key enabling 
technology in the performance of this clonogenic screen. Performing the same assay in a 
conventional multiwall format would need an average of 3,042 wells to be seeded, 
consuming eight 384-well plates, 1.2 L of culture media and 245.8 µg of Wnt-3a. 
Additionally, the micropallet array format allows for characterized clones to be sorted for 
further analysis, enabling future investigations into the molecular, genetic and epigenetic 
modulation of β-catenin signaling and the role that cell division may play in the mediation of 
positive and negative feedback. 
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Appendix: Creative Commons License 
This appendix contains the text of Creative Commons’ Attribution-NonCommercial-
NoDerivs License, version 4.0.1 
A.1 License Text 
By exercising the Licensed Rights (defined below), You accept and agree to be bound by the 
terms and conditions of this Creative Commons Attribution-NonCommercial-NoDerivatives 
4.0 International Public License ("Public License"). To the extent this Public License may be 
interpreted as a contract, You are granted the Licensed Rights in consideration of Your 
acceptance of these terms and conditions, and the Licensor grants You such rights in 
consideration of benefits the Licensor receives from making the Licensed Material available 
under these terms and conditions. 
Section 1 – Definitions. 
a. Adapted Material means material subject to Copyright and Similar Rights that is 
derived from or based upon the Licensed Material and in which the Licensed Material 
is translated, altered, arranged, transformed, or otherwise modified in a manner 
requiring permission under the Copyright and Similar Rights held by the Licensor. 
For purposes of this Public License, where the Licensed Material is a musical work, 
performance, or sound recording, Adapted Material is always produced where the 
Licensed Material is synched in timed relation with a moving image. 
                                                 
1 See: http://creativecommons.org/licenses/by-nc-nd/4.0/deed.en_US. 
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b. Copyright and Similar Rights means copyright and/or similar rights closely related 
to copyright including, without limitation, performance, broadcast, sound recording, 
and Sui Generis Database Rights, without regard to how the rights are labeled or 
categorized. For purposes of this Public License, the rights specified in 
Section 2(b)(1)-(2) are not Copyright and Similar Rights. 
c. Effective Technological Measures means those measures that, in the absence of 
proper authority, may not be circumvented under laws fulfilling obligations under 
Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or 
similar international agreements. 
d. Exceptions and Limitations means fair use, fair dealing, and/or any other exception 
or limitation to Copyright and Similar Rights that applies to Your use of the Licensed 
Material. 
e. Licensed Material means the artistic or literary work, database, or other material to 
which the Licensor applied this Public License. 
f. Licensed Rights means the rights granted to You subject to the terms and conditions 
of this Public License, which are limited to all Copyright and Similar Rights that 
apply to Your use of the Licensed Material and that the Licensor has authority to 
license. 
g. Licensor means the individual(s) or entity(ies) granting rights under this Public 
License. 
h. NonCommercial means not primarily intended for or directed towards commercial 
advantage or monetary compensation. For purposes of this Public License, the 
exchange of the Licensed Material for other material subject to Copyright and Similar 
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Rights by digital file-sharing or similar means is NonCommercial provided there is no 
payment of monetary compensation in connection with the exchange. 
i. Share means to provide material to the public by any means or process that requires 
permission under the Licensed Rights, such as reproduction, public display, public 
performance, distribution, dissemination, communication, or importation, and to 
make material available to the public including in ways that members of the public 
may access the material from a place and at a time individually chosen by them. 
j. Sui Generis Database Rights means rights other than copyright resulting from 
Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 
on the legal protection of databases, as amended and/or succeeded, as well as other 
essentially equivalent rights anywhere in the world. 
k. You means the individual or entity exercising the Licensed Rights under this Public 
License. Your has a corresponding meaning. 
Section 2 – Scope. 
a. License grant. 
1. Subject to the terms and conditions of this Public License, the Licensor hereby 
grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, 
irrevocable license to exercise the Licensed Rights in the Licensed Material 
to: 
A. reproduce and Share the Licensed Material, in whole or in part, for 
NonCommercial purposes only; and 
B. produce and reproduce, but not Share, Adapted Material for 
NonCommercial purposes only. 
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2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions 
and Limitations apply to Your use, this Public License does not apply, and 
You do not need to comply with its terms and conditions. 
3. Term. The term of this Public License is specified in Section 6(a). 
4. Media and formats; technical modifications allowed. The Licensor authorizes 
You to exercise the Licensed Rights in all media and formats whether now 
known or hereafter created, and to make technical modifications necessary to 
do so. The Licensor waives and/or agrees not to assert any right or authority to 
forbid You from making technical modifications necessary to exercise the 
Licensed Rights, including technical modifications necessary to circumvent 
Effective Technological Measures. For purposes of this Public License, 
simply making modifications authorized by this Section 2(a)(4) never 
produces Adapted Material. 
5. Downstream recipients. 
A. Offer from the Licensor – Licensed Material. Every recipient of the 
Licensed Material automatically receives an offer from the Licensor to 
exercise the Licensed Rights under the terms and conditions of this 
Public License. 
B. No downstream restrictions. You may not offer or impose any 
additional or different terms or conditions on, or apply any Effective 
Technological Measures to, the Licensed Material if doing so restricts 
exercise of the Licensed Rights by any recipient of the Licensed 
Material. 
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6. No endorsement. Nothing in this Public License constitutes or may be 
construed as permission to assert or imply that You are, or that Your use of 
the Licensed Material is, connected with, or sponsored, endorsed, or granted 
official status by, the Licensor or others designated to receive attribution as 
provided in Section 3(a)(1)(A)(i). 
b. Other rights. 
1. Moral rights, such as the right of integrity, are not licensed under this Public 
License, nor are publicity, privacy, and/or other similar personality rights; 
however, to the extent possible, the Licensor waives and/or agrees not to 
assert any such rights held by the Licensor to the limited extent necessary to 
allow You to exercise the Licensed Rights, but not otherwise. 
2. Patent and trademark rights are not licensed under this Public License. 
3. To the extent possible, the Licensor waives any right to collect royalties from 
You for the exercise of the Licensed Rights, whether directly or through a 
collecting society under any voluntary or waivable statutory or compulsory 
licensing scheme. In all other cases the Licensor expressly reserves any right 
to collect such royalties, including when the Licensed Material is used other 
than for NonCommercial purposes. 
Section 3 – License Conditions. 
Your exercise of the Licensed Rights is expressly made subject to the following conditions. 
a. Attribution. 
1. If You Share the Licensed Material, You must: 
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A. retain the following if it is supplied by the Licensor with the Licensed 
Material: 
i. identification of the creator(s) of the Licensed Material and any 
others designated to receive attribution, in any reasonable 
manner requested by the Licensor (including by pseudonym if 
designated); 
ii. a copyright notice; 
iii. a notice that refers to this Public License; 
iv. a notice that refers to the disclaimer of warranties; 
v. a URI or hyperlink to the Licensed Material to the extent 
reasonably practicable; 
B. indicate if You modified the Licensed Material and retain an indication 
of any previous modifications; and 
C. indicate the Licensed Material is licensed under this Public License, 
and include the text of, or the URI or hyperlink to, this Public License. 
For the avoidance of doubt, You do not have permission under this Public 
License to Share Adapted Material. 
2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner 
based on the medium, means, and context in which You Share the Licensed 
Material. For example, it may be reasonable to satisfy the conditions by 
providing a URI or hyperlink to a resource that includes the required 
information. 
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3. If requested by the Licensor, You must remove any of the information 
required by Section 3(a)(1)(A) to the extent reasonably practicable. 
Section 4 – Sui Generis Database Rights. 
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the 
Licensed Material: 
a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, 
reproduce, and Share all or a substantial portion of the contents of the database for 
NonCommercial purposes only and provided You do not Share Adapted Material; 
b. if You include all or a substantial portion of the database contents in a database in 
which You have Sui Generis Database Rights, then the database in which You have 
Sui Generis Database Rights (but not its individual contents) is Adapted Material; and 
c. You must comply with the conditions in Section 3(a) if You Share all or a substantial 
portion of the contents of the database. 
For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations 
under this Public License where the Licensed Rights include other Copyright and Similar 
Rights. 
Section 5 – Disclaimer of Warranties and Limitation of Liability. 
a.  Unless otherwise separately undertaken by the Licensor, to the extent possible, the 
Licensor offers the Licensed Material as-is and as-available, and makes no 
representations or warranties of any kind concerning the Licensed Material, whether 
express, implied, statutory, or other. This includes, without limitation, warranties of 
title, merchantability, fitness for a particular purpose, non-infringement, absence of 
latent or other defects, accuracy, or the presence or absence of errors, whether or not 
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known or discoverable. Where disclaimers of warranties are not allowed in full or in 
part, this disclaimer may not apply to You. 
b.  To the extent possible, in no event will the Licensor be liable to You on any legal 
theory (including, without limitation, negligence) or otherwise for any direct, special, 
indirect, incidental, consequential, punitive, exemplary, or other losses, costs, 
expenses, or damages arising out of this Public License or use of the Licensed 
Material, even if the Licensor has been advised of the possibility of such losses, costs, 
expenses, or damages. Where a limitation of liability is not allowed in full or in part, 
this limitation may not apply to You. 
c. The disclaimer of warranties and limitation of liability provided above shall be 
interpreted in a manner that, to the extent possible, most closely approximates an 
absolute disclaimer and waiver of all liability. 
Section 6 – Term and Termination. 
a. This Public License applies for the term of the Copyright and Similar Rights licensed 
here. However, if You fail to comply with this Public License, then Your rights under 
this Public License terminate automatically. 
b. Where Your right to use the Licensed Material has terminated under Section 6(a), it 
reinstates: 
1. automatically as of the date the violation is cured, provided it is cured within 
30 days of Your discovery of the violation; or 
2. upon express reinstatement by the Licensor. 
For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor 
may have to seek remedies for Your violations of this Public License. 
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c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under 
separate terms or conditions or stop distributing the Licensed Material at any time; 
however, doing so will not terminate this Public License. 
d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License. 
Section 7 – Other Terms and Conditions. 
a. The Licensor shall not be bound by any additional or different terms or conditions 
communicated by You unless expressly agreed. 
b. Any arrangements, understandings, or agreements regarding the Licensed Material 
not stated herein are separate from and independent of the terms and conditions of 
this Public License. 
Section 8 – Interpretation. 
a. For the avoidance of doubt, this Public License does not, and shall not be interpreted 
to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material 
that could lawfully be made without permission under this Public License. 
b. To the extent possible, if any provision of this Public License is deemed 
unenforceable, it shall be automatically reformed to the minimum extent necessary to 
make it enforceable. If the provision cannot be reformed, it shall be severed from this 
Public License without affecting the enforceability of the remaining terms and 
conditions. 
c. No term or condition of this Public License will be waived and no failure to comply 
consented to unless expressly agreed to by the Licensor. 
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d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, 
or waiver of, any privileges and immunities that apply to the Licensor or You, 
including from the legal processes of any jurisdiction or authority. 
A.2 Creative Commons Notice 
Creative Commons is not a party to its public licenses. Notwithstanding, Creative 
Commons may elect to apply one of its public licenses to material it publishes and in those 
instances will be considered the “Licensor.” Except for the limited purpose of indicating that 
material is shared under a Creative Commons public license or as otherwise permitted by the 
Creative Commons policies published at creativecommons.org/policies, Creative Commons 
does not authorize the use of the trademark “Creative Commons” or any other trademark or 
logo of Creative Commons without its prior written consent including, without limitation, in 
connection with any unauthorized modifications to any of its public licenses or any other 
arrangements, understandings, or agreements concerning use of licensed material. For the 
avoidance of doubt, this paragraph does not form part of the public licenses. Creative 
Commons may be contacted at creativecommons.org. 
